p08126 UIP Final 2009_107.indd - AIM Group
p08126 UIP Final 2009_107.indd - AIM Group
p08126 UIP Final 2009_107.indd - AIM Group
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
XVI<br />
WORLD MEETING<br />
OF THE<br />
UNION<br />
INTERNATIONALE<br />
DE PHLEBOLOGIE<br />
Under the High Patronage<br />
of His Serene Highness<br />
Prince Albert II of Monaco<br />
AUGUST 31 st<br />
SEPTEMBER 4 th , <strong>2009</strong><br />
GRIMALDI FORUM<br />
PRINCIPALITY OF MONACO<br />
<strong>Final</strong> Programme www.uip<strong>2009</strong>.eu
IMPORTANT ADDRESSES<br />
ORGANIZING AND SCIENTIFIC SECRETARIAT<br />
Publi Créations - Partner of <strong>AIM</strong><br />
E-mail: uip<strong>2009</strong>@publicreations.com<br />
www.uip<strong>2009</strong>.eu<br />
CONGRESS VENUE<br />
Grimaldi Forum<br />
74, Bd d’Italie - 98000 Monte-Carlo - Monaco<br />
Ph.: +377 97 97 3555 - Fax: +377 97 97 3550<br />
Avenue Princesse Grace - 98000 Monte-Carlo - Monaco<br />
Ph.: +377 99 99 2000 - Fax: +377 99 99 2001<br />
E-mail: gf@grimaldiforum.mc<br />
www.grimaldiforum.mc
T A B L E O F C O N T E N T S<br />
INTERNATIONAL SCIENTIFIC ADVISORY BOARD 4<br />
COMMITTEES 5<br />
WELCOME TO MONACO 6<br />
ACKNOWLEDGMENTS 7<br />
PROGRAMME AT A GLANCE 8<br />
SCIENTIFIC PROGRAMME 10<br />
LIST OF ACCEPTED POSTERS 40<br />
LIST OF ACCEPTED VIDEOS 41<br />
SCIENTIFIC INFORMATION 42<br />
EXHIBITION PLAN 44<br />
LIST OF EXHIBITORS 45<br />
GENERAL INFORMATION 46<br />
MONACO CITY MAP 50<br />
3
4<br />
INTERNATIONAL SCIENTIFIC ADVISORY BOARD<br />
G. AGUS (Italy)<br />
Y. AKSALI (Turkey)<br />
C. ALLEGRA (Italy)<br />
E. ALTMANN-CANESTRI (Argentina)<br />
M. ANDRADE (Brasil)<br />
F.A. ALLAERT (France)<br />
P.L. ANTIGNANI (Italy)<br />
J. BARRETT (New Zealand)<br />
J.P. BENIGNI (France)<br />
J. BERGAN (USA)<br />
I. BIHARI (Hungary)<br />
W. BLÄTTLER (Switzerland)<br />
V. BLAZEK (Germany)<br />
E. BLIN (France)<br />
F. BOCCARDO (Italy)<br />
P. BOIVIN (France)<br />
S. BOUSETTA (France)<br />
A. BRADBURY (United Kingdom)<br />
L.BRAJESH (United Kingdom)<br />
M. BRAVO-MARTINEZ (Chile)<br />
E. BRIZZIO (Argentina)<br />
K. BURNAND (United Kingdom)<br />
A. CAGGIATI (Italy)<br />
C. CAMPISI (Italy)<br />
M. CAPPELLI (Italy)<br />
P. CARPENTIER (France)<br />
M. CAUZABON (France)<br />
A. CAVEZZI (Italy)<br />
J.M. CHARDONNEAU (France)<br />
F. CHLEIR (France)<br />
D. CHRISTIAN (France)<br />
R. COHEN (Israel)<br />
P. COLERIDGE SMITH (United Kingdom)<br />
A. COMEROTA (USA)<br />
P. CONRAD (Australia)<br />
A. CORNU-THÉNARD (France)<br />
D. CRETON (France)<br />
M. DALSING (USA)<br />
D. DAMSTRA (The Netherlands)<br />
A. DAVIES (United Kingdom)<br />
E. DE BOER (The Netherlands)<br />
M. DE MAESENER (Belgium)<br />
J.J. DITMAR (Brasil)<br />
J.U. DOMINGUEZ (Colombia)<br />
I. DRESCIK (Croatia)<br />
J.L. DUPUIS (Canada)<br />
B. EKLÖF (Sweden)<br />
E. A. ENRICI (Argentina)<br />
M.E. ENRIQUEZ VEGA (Mexico)<br />
M. FLOUR (The Netherlands)<br />
H. FRONEK (USA)<br />
A. FRULLINI (Italy)<br />
G. GALLENKEMPER (Germany)<br />
V. GASBARRO (Italy)<br />
A. GASPARIS (USA)<br />
G. GENOVESE (Italy)<br />
H. GERLACH (Germany)<br />
A. GIANNOUKAS (Greece)<br />
J.L. GILLET (France)<br />
P. GLOVICZKI (USA)<br />
J.P. GOBIN (France)<br />
M. GOLDMAN (USA)<br />
P. GUALTIERO (Italy)<br />
C.H. DESNOS (France)<br />
K. HARTMANN (Germany)<br />
H.J. HERMANNS (Germany)<br />
S. HOSHINO (Japan)<br />
E. A. HUSSEIN (Egypt)<br />
E. INTRIAGO-GILER (Ecuador)<br />
T. IWAI (Japan)<br />
G. JANTET (France)<br />
C. JEANNERET (Switzerland)<br />
M. JÜNGER (Germany)<br />
L. KABNICK (USA)<br />
B. KAHLE (Germany)<br />
D.I KIM (Korea)<br />
R. KISTNER (USA)<br />
H. KLUESS (Germany)<br />
L. KOLLAR (Hungary)<br />
J.P. K<strong>UIP</strong>ER (The Netherlands)<br />
S. KÜPFER (Switzerland)<br />
M. KURTOGLU (Turkey)<br />
N. LABROPOULOS (USA)<br />
J. LAREDO (USA)<br />
B.B. LEE (USA)<br />
M.L. VILLARDEBO (France)<br />
J. LOHR (USA)<br />
D. LOOSE (Germany)<br />
M. LUGLI (Italy)<br />
F. LURIE (USA)<br />
V. M. CANATA (Paraguay)<br />
O. MALETI (Italy)<br />
M. MALOUF (Australia)<br />
S. MANCINI (Italy)<br />
M. MARSHALL (Germany)<br />
R. MATTASSI (Italy)<br />
J. MAURIELLO (USA)<br />
M. MEISSNER (USA)<br />
S. MICHELINI (Italy)<br />
R. J. MIN (USA)<br />
N. MORRISON (USA)<br />
P. MORTIMER (United Kingdom)<br />
A. MUMME (Germany)<br />
K. MYERS (Australia)<br />
P. NEGLEN (USA)<br />
O. NELZÉN (Sweden)<br />
D. NEUHARDT (USA)<br />
H.M. NEUMANN (The Netherlands)<br />
A. NICOLAIDES (Cyprus)<br />
J. NIGRO (Argentina)<br />
T. NOPPENEY (Germany)<br />
F. PADBERG (USA)<br />
F. PANNIER (Germany)<br />
K. PARSI (Australia)<br />
H. PARTSCH (Austria)<br />
M. PATEL (India)<br />
M. PERRIN (France)<br />
O. PICHOT (France)<br />
N. PILLER (Australia)<br />
P. PITTALUGA (France)<br />
I. PIZARRO (Chile)<br />
P. POLTERAUER (Austria)<br />
P. PORTALES (Chile)<br />
T. PROEBSTLE (Germany)<br />
E. RABE (Germany)<br />
S. RAJU (USA)<br />
D. RAMAKRISHNA (India)<br />
A.A.RAMELET (Switzerland)<br />
P. RAYMOND-MARTIMBEAU (Canada)<br />
S. RICCI (Italy)<br />
L. RILANTONIO (Indonesia)<br />
A. ROMANO (Argentina)<br />
N. ROSLI (Argentina)<br />
P. ROTH (France)<br />
W. SALMHOFER (Austria)<br />
M. SCHADECK (France)<br />
A. SCHAPIRA (Argentina)<br />
L. SCHIMMELPFENNIG (Germany)<br />
J.C. SCHOEVARDTS (Belgium)<br />
S. SCHULLER-PETROVIC (Austria)<br />
C. SCHWAHN-SCHREIBER (Germany)<br />
A. SCUDERI (Brasil)<br />
J. SEYCEK (Czech Republic)<br />
M. SICA (France)<br />
R. SIMKIN (Argentina)<br />
A. SOMMER (The Netherlands)<br />
I. STAELENS (Belgium)<br />
H. STEGE (Germany)<br />
D. STENGER (Germany)<br />
J. STREJCEK (Czech Republic)<br />
M. STÜCKER (Germany)<br />
K. SVATOPLUK (Czech Republic)<br />
J.F. UHL (France)<br />
J. VAN DER STRICHT (Belgium)<br />
A. VAN RIJ (New Zealand)<br />
R. VARNAGY (Venezuela)<br />
F. VEGA RASGADO (Mexico)<br />
L. VILLAVICENCIO (USA)<br />
F. VIN (France)<br />
T. WAKEFIELD (USA)<br />
P. WALLOIS (France)<br />
V. WIENERT (Germany)<br />
R. WINTERBORN (United Kingdom)<br />
C. WITTENS (The Netherlands)<br />
T. YAMAKI (Japan)<br />
P. ZAMBONI (Italy)<br />
S. ZIMMET (USA)
ORGANIZING COMMITTEE<br />
Chairman<br />
Dr Jean-Jérôme GUEX (Nice, FRANCE)<br />
Co-chairman<br />
Dr Horst GERLACH (Mannheim, GERMANY)<br />
C O M M I T T E E S<br />
<strong>UIP</strong> Board<br />
President of Honour Founder<br />
Raymond TOURNAY ✝<br />
Presidents of Honour<br />
Hendrick Roelof VAN DER MOLEN ✝ - Jean VAN DER STRICHT - André DAVY<br />
Georges JANTET - Hugo PARTSCH<br />
President<br />
Eberhard RABE<br />
Past President<br />
Claudio ALLEGRA<br />
Vice Presidents<br />
John J. BERGAN - Byung Boong LEE - Mark MALOUF<br />
Angelo SCUDERI - Jaroslav STREJCEK<br />
General Secretary<br />
Ivan STAELENS<br />
Assistant General Secretary<br />
André CORNU THENARD<br />
Treasurer<br />
Jean-Jérôme GUEX<br />
Founding Members<br />
M. AUDIER ✝ - G. BASSI ✝ - M. COMEL ✝ - C. HURIEZ ✝ - J. MARMASSE ✝<br />
R. TOURNAY ✝ - H.R. VAN DER MOLEN ✝ - P. WALLOIS<br />
<strong>UIP</strong> Committee of Honour<br />
P. CONRAD - A. DAVY - S. HOSHINO<br />
G. JANTET - J.P. K<strong>UIP</strong>ER - H. PARTSCH<br />
SCIENTIFIC COMMITTEE<br />
Chairman<br />
Prof. Eberhard RABE (Bonn, GERMANY)<br />
Co-chairman<br />
Dr Michel SCHADECK (Paris, FRANCE)<br />
M. PERRIN - A. A. RAMELET - P. RAYMOND-MARTIMBEAU<br />
N. ROSLI - J. VAN DER STRICHT - S. UMANSKY - P. WALLOIS<br />
5
6<br />
W E L C O M E T O M O N A C O<br />
Dear Participants,<br />
Dear Colleagues and Friends,<br />
It gives me great pleasure to welcome you to the Principality of Monaco and I am<br />
proud to host the 16 th World Meeting of the “Union Internationale de Phlébologie”.<br />
I sincerely hope that you will have the opportunity to discover or rediscover Monaco<br />
during your short stay with us.<br />
The Monaco Convention Bureau’s team, together with the travel and tourism<br />
industry partners of the Principality are at your full disposal.<br />
Please do not hesitate to challenge us for any question or request you may have.<br />
I do wish you a highly productive Congress and a very enjoyable stay with us.<br />
Kindest regards,<br />
Michel BOUQUIER<br />
President<br />
Monaco Government Tourist<br />
and Convention Authority<br />
On behalf of the French and German societies of<br />
Phlebology, we welcome you to the XVI World Meeting<br />
of the Union Internationale de Phlébologie.<br />
This congress celebrates the 50 th anniversary of the<br />
Union founded in Meyrargues , not far from Monaco.<br />
For the first time, a meeting of the <strong>UIP</strong> is organized by<br />
two countries in the capital of the third one. These facts<br />
explain the name and the logo of the meeting.<br />
The phlebological community can be proud of the<br />
progress obtained in the last fifteen years. Care given to<br />
venous patients is more and more efficient, quick, painless and durable. The incidence of most severe<br />
forms of chronic venous disorders decreases because we have treated patients earlier and better. The<br />
new electronic media have accelerated diffusion of information and international cooperation. And<br />
finally, Evidence Based Phlebology exits.<br />
This meeting will be the occasion to summarize the latest progress, to update our knowledge and to devise<br />
new research, it is the place where you will meet with colleagues and make new friends from overseas.<br />
We are certain that you will enjoy the program, the venue, the country and all the opportunities that<br />
we have planned for you.<br />
However, take some time to visit this lovely country and discover its mediterranean magic.<br />
Dr. Jean-Jerôme GUEX<br />
Chairman of the Organizing Committee<br />
Prof. Eberhard RABE<br />
Chairman of the Scientific Committee
A C K N O W L E D G M E N T S<br />
The Organizing and Scientific Committees express their gratitude to the following Companies<br />
for their generous contribution to the success of the congress:<br />
PLATINUM SPONSORS<br />
Bauerfeind AG is one of the leading manufacturers<br />
of medical aids such as compression stockings,<br />
supports, orthoses, orthopedic insoles and<br />
prosthetic components. The high-quality products<br />
with the respected „Made in Germany“ label<br />
make an important contribution to maintaining<br />
and restoring health.<br />
Servier is a private, independent French<br />
pharmaceutical company, led by the founder Dr<br />
Jacques Servier. Servier is involved in research<br />
and development, manufacture and marketing<br />
of ethical pharmaceuticals, and is present in<br />
140 countries. Discovery of major innovative<br />
treatments have been achieved, among them<br />
Protelos, Procoralan, Valdoxan and Daflon<br />
500mg (Micronized Purified Flavonoid Fraction):<br />
the most prescribed venoactive drug in the world<br />
acting at the core of venous inflammation.<br />
GOLD SPONSORS<br />
SILVER SPONSORS<br />
Pierre Fabre is a French private group developing, manufacturing and<br />
distributing ethical and pharmaceutical, OTC and dermo-cosmetic<br />
products. Pierre Fabre achieved a turnover of 1.75 billion euros in 2008<br />
and employs 9,800 persons in over 40 countries. 1,400 employees<br />
are in the field of research, to which Pierre Fabre dedicates 25% of<br />
its pharmaceutical turnover in five major therapeutic axes: oncology,<br />
cardiovascular, central nervous system, urology and dermatology.<br />
BRONZE SPONSORS<br />
Kreussler Pharma, founded in 1912,<br />
is the inventor and manufacturer of<br />
Aethoxysklerol®, the leading sclerosing<br />
agent for varicose vein therapy with<br />
252,500,000 millilitres used worldwide<br />
since 1987, allowing to perform more than 100,000,000 efficacious<br />
and safe sclerotherapy treatments.<br />
Medical devices from medi (with a focus on<br />
compression therapy) ensure successful<br />
treatment in over 90 countries all over the world.<br />
medi products “made in Germany” can be found<br />
in specialist medical retailers, in hospitals and<br />
clinics as well as in doctors’ and therapists’<br />
practices.<br />
150 years of expertise and presence on the market. The family business takes its roots in Winterthur - Switzerland,<br />
in the heart of Europe, in 1864. It is now run by the fifth generation which continues to perpetuate the SIGVARIS<br />
tradition and know-how based on a solid and visionary strategy. Over 50 years ago, the company took a decisive turn<br />
to focus on a core activity: producing medical compression stockings as a solution for treatment of venous disease.<br />
Today, over 60 millions of legs have worn SIGVARIS medical compression stockings worldwide. 1200 employees<br />
spread over eight companies of the SIGVARIS <strong>Group</strong> are committed to providing «Life for Legs» to people suffering<br />
from venous disease, and are contributing each day to making SIGVARIS the world leader and expert number one<br />
in medical compression stockings<br />
BSN medical with it’s well-known brands – RADIANTE® and JOBST® – is<br />
a worldwide leading company in the compression therapy market and a<br />
solutions provider for wound care and orthopaedics (fracture management<br />
and physiotherapy).<br />
STD Pharmaceutical Products Ltd is a family run business<br />
supporting sclerotherapists. We provide a sclerosant,<br />
Fibro-Vein, plus needles, syringes & bandages. We<br />
also promote iontophoresis, an effective treatment for<br />
hyperhidrosis of the hands, feet & axillae.<br />
VENOSAN® Medical Stockings from<br />
the SALZMANN GROUP - ST.GALLEN -<br />
SWITZERLAND - Innovation in compression<br />
therapy, bringing an improvement to quality of<br />
life for patients in more than 60 countries around<br />
the world.<br />
Leader in compression therapy since 1926, Gloria-Med-<strong>Group</strong><br />
means highest quality in medical compression stockings, support<br />
socks/pantyhose, anti-embolism stockings and elastic bandages.<br />
Manufactured to strict specifications, stockings are offered in various<br />
fabrics, compression classes, styles and colours. Gloria-Med-<strong>Group</strong><br />
range includes Cosmeceutics, Nutraceutics, Sclerotherapy products,<br />
Diagnostics and Vascular instruments. Our long experience and constant medical research in the<br />
field of veno-lymphatic disorders is guarantee for a better patient compliance.<br />
7
8<br />
P R O G R A M M E A T A G L A N C E<br />
MONDAY, AUGUST 31st SESSION CODE<br />
Talk to the experts - Lasers and veins AP1.1<br />
07.30 - 08.45 Talk to the experts - Diagnostic approach to venous malformations BO1.1<br />
Talk to the experts - Sclerotherapy treatment of reticular and telangiectatic veins GE1.1<br />
09.00 - 10.00 <strong>UIP</strong> News, Awards PP1.2<br />
10.00 - 11.00 Venous Malformations and Lymphoedema PP1.3<br />
11.30 - 12.20 Guest lecture - Phlebology in the last 50 years: Varicose Veins and Venous Ulcers PP1.4<br />
12.20 - 13.00 Venous symptoms and clinical assessment PP1.5<br />
13.00 - 14.00 STD Pharmaceutical Symposium - Foam sclerotherapy in <strong>2009</strong> (Lunch session) CB1.6<br />
13.00 - 15.00 Council Meeting (by invitation: presidents of members of societies and board members)<br />
14.00 - 15.00 Presentation of posters by authors: posters DIA1 to DIA16 CB1.6<br />
Endovenous Procedures 1 - Diagnosis and Anesthesia PP1.7<br />
14.00 - 16.00 Sclerotherapy 1 - Basic consideration AP1.7<br />
Compression Treatment 1- Pressure measurements GE1.7<br />
14.30 - 15.15 Pierre Fabre Symposium - 1st part. CB1.8<br />
Venous ulcer: the fi nal stage in chronic venous disease - Managing it in <strong>2009</strong><br />
CB1.8<br />
15.30 - 16.15 Pierre Fabre Symposium - 2nd I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I part. Compression therapy: new device I<br />
I I CB1.9<br />
15.30 - 17.30 I Session of the Latin American Chapter I<br />
I I SC1.9<br />
16.30 - 17.15 I Max Ratschow Medal Session (Collegium Internationalis Angiologiae) I<br />
I I AP1.10<br />
I Endovenous Procedures 2 - Comparative Studies I<br />
I I PP1.11<br />
I<br />
16.30 - 18.30<br />
ICC Symposium: New methods to evaluate compression therapy I CB1.11<br />
I I<br />
I Session of the Asian and Australasian Chapter I BO1.11<br />
I I<br />
I Venous Anatomy and Epidemiology I GE1.11<br />
17.15 - 18.30<br />
I<br />
Venous Malformation<br />
I<br />
I I<br />
AP1.12<br />
TUESDAY, SEPTEMBER 1st I SESSION I<br />
I I CODE<br />
I<br />
Talk to the experts - The Neovalve in PTS - tips and tricks<br />
I<br />
I I AP2.1<br />
07.30 - 08.45 I Talk to the experts - My technique in compression treatment - bandages or stockings I<br />
I I BO2.1<br />
I Talk to the experts - Esthetic treatments and phlebology practice I<br />
I I<br />
GE2.1<br />
09.00 - 11.00 I Thromboembolic Disease I PP2.2<br />
I I<br />
11.30 - 12.00 I Guest lecture - Why do varicose veins develop? I PP2.3<br />
12.00 - 13.00<br />
I<br />
<strong>UIP</strong> Consensus Varicose Veins<br />
I<br />
I I PP2.4<br />
I Session of the German Society of Phlebology (Board meeting) - (by invitation only) I AP2.5<br />
13.00 - 14.00 I I<br />
I VNUS Workshop I<br />
I I<br />
BO2.5<br />
14.00 - 15.00 I Presentation of posters by authors: posters DIA17 to DIA31 I CB1.6<br />
I I<br />
I Servier Symposium - Management of chronic venous disease: I CB2.6<br />
14.00 - 15.30 I I CB2.6<br />
I therapeutic recommendations<br />
I<br />
I I<br />
I Sclerotherapy 2 - Miscellaneous I PP2.6<br />
I I<br />
14.00 - 16.00 I Endovenous Procedures 3 - Prospective Studies I AP2.6<br />
I<br />
Session of the German Society of Phlebology: Varicose Veins and Venous Ulcers<br />
I<br />
I I BO2.6<br />
I Short free paper Session I I<br />
I I GE2.6<br />
15.30 - 16.00 I Lecture: Microcirculation in Phlebology I<br />
I I CB2.7<br />
I Sclerotherapy 3 - Safety Aspects I<br />
I I<br />
PP2.8<br />
I Venous Pathophysiology I CB2.8<br />
I I<br />
16.30 - 18.30 I Endovenous Procedures 4 - Wavelength and new Fibres I AP2.8<br />
I<br />
Session of the German Society of Phlebology: Endovenous treatment: Obesity and CVI<br />
I<br />
I I BO2.8<br />
I Venous Diagnosis 1 I<br />
I I GE2.8<br />
WEDNESDAY, SEPTEMBER 2nd SESSION CODE<br />
Talk to the experts - 3D-Imaging of the venous system AP3.1<br />
07.30 - 08.45 Talk to the experts - Closure fast - indications and how to do it BO3.1<br />
Talk to the experts - Duplex of the deep veins - tips and tricks GE3.1<br />
09.00 - 09.45 Special issue in Phlebology PP3.2<br />
09.45 - 11.00 Chronic Cerebro - Spinal Venous Insuffi ciency (CCSVI): Diagnosis and treatment PP3.3<br />
11.30 - 12.00 Guest lecture - Asymptomatic deep venous thrombosis PP3.4<br />
12.00 - 13.00 <strong>UIP</strong> Consensus - Curriculum in Phlebology PP3.5<br />
13.00 - 14.00 Session of the German Society of Phlebology - Bauerfeind award - Hartmann price AP3.6<br />
13.00 - 15.00 Council Meeting (by invitation: presidents of members of societies and board members) GE3.1<br />
14.00 - 15.00 Presentation of posters by authors: posters DIA32 to DIA46<br />
Medi Symposium - Compression therapy after surgery and endovenous procedures PP3.7<br />
Endovenous procedures 5 - RFA CB3.7<br />
14.00 - 16.00 Sclerotherapy 4 - Teleangiectasias and Reticular Veins AP3.7<br />
Session of the French Society of Phlebology<br />
1st BO3.7<br />
part: Cooperative studies of the French Society of Phlebology<br />
Lymphoedema / Pelvic Veins GE3.7<br />
Endovenous Procedures 6 - Combined Treatment PP3.8<br />
Venous Surgery 1 CB3.8<br />
Bauerfeind Symposium - The venous ulcer - patient between compression and intervention AP3.8<br />
16.30 - 18.30<br />
Session of the French Society of Phlebology - 2nd I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I I<br />
I part: Treatment of chronic venous disorders: I BO3.8<br />
I<br />
French and Russian convergences<br />
I<br />
I I BO3.8<br />
I Venous ulcer Treatment - Grafts I<br />
I I GE3.8
LEGEND<br />
EXAMPLE: PP1.1-1<br />
PP<br />
ROOM<br />
P R O G R A M M E A T A G L A N C E<br />
THURSDAY, SEPTEMBER 3rd I I<br />
I I<br />
I SESSION I CODE<br />
I I<br />
I Talk to the experts - Interaction of Detergent Sclerosants with the coagulation system: I<br />
I I AP4.1<br />
I an update I<br />
I I<br />
AP4.1<br />
07.30 - 08.45 I Talk to the experts - DVT - How to treat in daily practice? I BO4.1<br />
I I<br />
I Talk to the experts - Radiofrequency and Laser Venous Ablation: Results and Complications I GE4.1<br />
09.00 - 11.00<br />
I<br />
Varicose Veins<br />
I<br />
I I PP4.2<br />
11.30 - 12.00 I Guest lecture - Chronic venous Insuffi ciency - Think obstruction I<br />
I I PP4.3<br />
12.00 - 13.00 I <strong>UIP</strong> Consensus Venous Oedema & Skin changes I<br />
I I<br />
PP4.4<br />
13.00 - 14.00 I Servier Vein Consult Project I BO4.5<br />
I I<br />
13.00 - 15.00 I Session of the German Society of Phlebology - General Assembly I AU4.5<br />
14.00 - 15.00<br />
I<br />
Presentation of posters by authors: posters DIA47 to DIA61<br />
I<br />
I I CB1.6<br />
I Sclerotherapy 5 - Saphenous Veins I<br />
I I PP4.6<br />
I Joint Symposium on Phlebolymphedema<br />
I<br />
I I CB4.6<br />
14.00 - 16.00<br />
I International Union of Phlebology & European Society of Lymphology<br />
I<br />
I I<br />
I Endovenous Procedures 7 - Complications I AP4.6<br />
I<br />
Session of the American Venous Forum<br />
I<br />
I I BO4.6<br />
I Short Free Paper Session II I<br />
I I GE4.6<br />
I Venous Diagnosis 2 I<br />
I I<br />
PP4.7<br />
I BSN JOBST Symposium - Patient compliance in compression therapy - Does it really matter? I CB4.7<br />
I I<br />
16.30 - 18.30 I Thromboembolic Diseases 1 I AP4.7<br />
I<br />
Session of the American College of Phlebology<br />
I<br />
I I BO4.7<br />
I Short Free Paper Session III I<br />
I I<br />
GE4.7<br />
FRIDAY, SEPTEMBER 4th I SESSION I<br />
I I CODE<br />
I<br />
Talk to the experts - Foam Sclerotherapy and phlebectomy - what are the best strategies?<br />
I<br />
I I AP5.1<br />
07.30 - 08.45 I Talk to the experts - Ilio-femoral obstruction - how to treat the disease? I<br />
I I BO5.1<br />
I Talk to the experts - US Guided foam sclerotherapy: references and practical applications I<br />
I I<br />
GE5.1<br />
09.00 - 11.00 I Deep Venous Insuffi ciency I PP5.2<br />
I I<br />
11.30 - 12.00 I Guest lecture - Embryology of the venous network I PP5.3<br />
12.00 - 13.00<br />
I<br />
<strong>UIP</strong> Consensus Venous Malformation & Lymphoedema<br />
I<br />
I I PP5.4<br />
I Endovenous Procedures 8 - Treatment / Sclerotherapy 6 - Safety I<br />
I I PP5.6<br />
I Sigvaris Symposium - Medical compression Stockings (MCS) for venous disorders and I<br />
I I<br />
CB5.6<br />
CB5.6<br />
I diseases - original studies presented by the authors<br />
I<br />
I I<br />
14.00 - 16.00 I Varicose Veins - Miscellaneous I AP5.6<br />
I<br />
Session of the European Venous Forum - Workshop on updating international<br />
I<br />
I I<br />
I BO5.6<br />
guidelines on the prevention of venous thromboembolism<br />
I<br />
I I<br />
I Venous Surgery 2 I<br />
I I<br />
GE5.6<br />
I Venous Ulcer Treatment II I PP5.7<br />
I I<br />
I Short Free Paper Session IV I AP5.7<br />
16.30 - 18.30<br />
I<br />
Session of the Italian College of Phlebology - Endovascular treatment of Varicose Veins<br />
I<br />
I I BO5.7<br />
I Thromboembolic disease II I<br />
I I GE5.7<br />
1<br />
DAY<br />
.<br />
1<br />
SESSION<br />
S C I E N T I F I C P R O G R A M M E<br />
Sunday, August 30 th<br />
09.00-18.30 <strong>UIP</strong> Pre-Conference (by invitation only)<br />
Prince Pierre<br />
18.30-19.30 Opening Ceremony<br />
Exhibition hall Diaghilev<br />
19.30-21.00 Welcome Reception<br />
-<br />
1<br />
PRESENTATION<br />
Morning Afternoon Sponsored Symposia<br />
ROOMS DAYS<br />
PP = PRINCE PIERRE 1 = MONDAY<br />
AP = APOLLINAIRE 2 = TUESDAY<br />
GE = GENEVOIX 3 = WEDNESDAY<br />
BO = BOSIO 4 = THURSDAY<br />
CB = CAMILLE BLANC<br />
SC = SCOTTO<br />
5 = FRIDAY<br />
9
10<br />
S C I E N T I F I C P R O G R A M M E<br />
Monday, August 31 st<br />
07.30-08.45<br />
Apollinaire Talk to the experts (AP1.1)<br />
R. Weiss: Lasers and veins<br />
A.A. Ramelet: discussant moderator<br />
Bosio Talk to the experts (BO1.1)<br />
B.B. Lee: Diagnostic approach to venous malformations<br />
M. Meissner: discussant moderator<br />
Genevoix Talk to the experts (GE1.1)<br />
J.J. Guex: Sclerotherapy treatment of reticular and telangiectatic veins<br />
S. Zimmet: discussant moderator<br />
08.45-09.00 Coffee break in Exhibition hall<br />
09.00-10.00<br />
Prince Pierre <strong>UIP</strong> News, Awards (PP1.2)<br />
Chairpersons: E. Rabe, J.J. Guex<br />
PP1.2-1 E. Rabe, J.J. Guex: Welcome, News from <strong>UIP</strong><br />
PP1.2-2 Report of last winners:<br />
C. Rosi: <strong>UIP</strong>-Servier Research Fellowship<br />
R. Ceulen: Bauerfeind Award<br />
PP1.2-3 New awards:<br />
- Servier Research Fellowship<br />
- Bauerfeind Award<br />
- 1 st Kreussler Young Scientists’ Sclerotherapy Award<br />
PP1.2-4 N. Morrison, A. Cavezzi: Charity activities in phlebology<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
10.00-11.00<br />
Prince Pierre Venous Malformations and Lymphoedema (PP1.3)<br />
Chairperson: B.B. Lee<br />
Moderator: N. Piller<br />
PP1.3-1 B.B. Lee: Venous Malformation: it is not an AV-Malformation<br />
PP1.3-2 A. Caggiati: New nomenclature of embryological veins<br />
PP1.3-3 R.J. Damstra, H. Partsch: Comparative, prospective study between volume<br />
and low and high interface pressure under short stretch compression bandages<br />
in the treatment of breast cancer lymphedema<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
11.00-11.30 Coffee break in Exhibition hall<br />
11.30-12.20<br />
Prince Pierre Guest lecture (PP1.4)<br />
Chairperson: J. Bergan<br />
K. Burnand, C. Jeanneret: Phlebology in the last 50 years:<br />
varicose veins and venous ulcers<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
12.20-13.00<br />
Prince Pierre Venous symptoms and clinical assessment (PP1.5)<br />
Chairperson: B. Eklöf<br />
Moderator: P. Carpentier<br />
PP1.5-1 P. Carpentier: Venous symptoms: Evolution of the concept<br />
PP1.5-2 N. Danziger: Pathophysiology of pain in chronic venous disease<br />
PP1.5-3 M. Vasquez, J.J. Guex: Our obligation to follow clinical outcome<br />
in venous disease<br />
PP1.5-4 B. Eklöf: CEAP Classification: what is the future?<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)
13.00-14.00<br />
Camille Blanc STD Pharmaceutical Symposium (Lunch session) (CB1.6)<br />
Foam Sclerotherapy in <strong>2009</strong><br />
Chairperson: L. Tessari<br />
CB1.6-1 P. Coleridge-Smith: Foam Sclerotherapy- the State of the Art<br />
CB1.6-2 A. Cavezzi: Foam Sclerotherapy in Italy with Post Sclerotherapy Compression<br />
CB1.6-3 M. Perrin: Recurrent Varicose Veins - Foam Sclerotherapy<br />
CB1.6-4 A. Bradbury: Foam Sclerotherapy treatment in varicose veins-results<br />
from 1200 cases<br />
Panel Discussion & Question<br />
13.00-15.00<br />
Auric Council meeting (by invitation: presidents of member societies and board members)<br />
14.00-15.00<br />
Presentation of posters by authors: posters DIA 1 to 16<br />
Chairpersons: M. Schadeck, H. Gerlach<br />
Discussants : P. Raymond-Martimbeau, F. Vin<br />
MONDAY, AUGUST 31 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
14.00-16.00<br />
Prince Pierre Free Paper Session: Endovenous Procedures 1 - Diagnosis and Anesthesia (PP1.7)<br />
Chairperson: R. Weiss<br />
Moderator: S. Kaspar<br />
PP1.7-1 C. Lebard: Apport de la mesure échodoppler du diamètre de la grande veine<br />
saphène pour le calcul d’énergie au cours des traitements endoveineux<br />
PP1.7-2 J. Ferreira: Ultrasound signals to control the closure process in real time<br />
in endovenous ablations<br />
PP1.7-3 G Peruzzi: Endovenous laser ablation of incompetent saphenous veins. inclusion<br />
criteria by preoperative duplex examination<br />
PP1.7-4 G. Serpieri: Auto-fill syringe for echoguided tumescent local anesthesia during<br />
endovenous laser procedure in the treatment of lower limbs varicose veins<br />
PP1.7-5 J. Ferreira: Selective nerve block under us guidance to perform endovenous<br />
laser ablation<br />
PP1.7-7 P.W. Sridhar: Patient preference for local or general anaesthesia during<br />
endovenous laser ablation and phlebectomy of symptomatic varicose veins<br />
PP1.7-8 J. Klein: Maximum safe lidocaine dosage for tumescent anesthesia without<br />
liposuction is 45 mg/kg<br />
PP1.7-9 G. Serpieri: Endovascular technologies for lower limbs varicose veins treatment<br />
PP1.7-10 M.Vuylsteke: Endovenous laser treatment: a morphological study<br />
in an animal model<br />
PP1.7-11 K. Kikuchi: Clinical comparison of long pulse nd: yag laser versus foam<br />
sclerotherapy in the treatment of leg veins<br />
Apollinaire Free Paper Session: Sclerotherapy 1- Basic consideration (AP1.7)<br />
Chairperson: T. Yamaki<br />
Moderator: F.X. Breu<br />
AP1.7-1 F. Bastos: Refléxions sur l’inclusion sociale par la mousse sclerosante<br />
AP1.7-2 S. Sadoun: Proposition of a mathematical model to calculate the efficacy<br />
of the sclerosing foam by analogy with the laser biological effect<br />
AP1.7-3 F. Passariello: Geometrical properties of sclerosing foam in several drainage<br />
phases in constrained or free environments<br />
AP1.7-4 K. Parsi: The lytic effects of detergent sclerosants on erythrocytes, platelets,<br />
endothelial cells and microparticles are attenuated by albumin and other plasma<br />
components in vitro<br />
AP1.7-5 K. Parsi: In vitro effects of detergent sclerosants on antithrombotic mechanisms<br />
AP1.7-6 D. Hill: Effect of a 5 micron filter on CO2 sclerosant foam stability<br />
AP1.7-7 L. Tessari: “Tessari method for foam sclerotherapy”<br />
(10 years of history of technology that changed the world of phlebology)<br />
11
12<br />
MONDAY, AUGUST 31 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
AP1.7-8 A. Cavezzi: Variables in foam sclerotherapy with Tessari method: experimental data<br />
AP1.7-9 G. Gachet: Recommendations on the endovascular treatment of varicose veins<br />
by echo-guided injections of sclerosing foam: the Grenoble Consensus of expert<br />
2008 version<br />
AP1.7-10 G. Gachet: The SOV concept: an easier safer method for abolition of great<br />
saphenous incompetence with echo guided sclerotherapy<br />
AP1.7-11 R. Milleret: Obliteration of varicose veins by hyperheated steam<br />
Genevoix Free Paper Session: Compression Treatment 1 - Pressure measurements (GE1.7)<br />
14.00-16.00 Chairperson: Z. Maksimovic<br />
Moderator: A. Cornu-Thénard<br />
GE1.7-1 G. Mosti: Superiority of short-stretch bandages to improve venous pumping<br />
function<br />
GE1.7-2 B. Partsch: Superposition of two light stockings. Measurement of interface<br />
pressure and stiffness in vivo and in vitro<br />
GE1.7-3 J.F. Uhl: Superimposition of MCS in vivo: interface pressure and stiffness index<br />
measurements<br />
GE1.7-4 M. Juenger: Interface pressure of three different multi-layer bandage systems<br />
in healthy volunteers ; results of a prospective randomized clinical study<br />
GE1.7-5 G. Mosti: Which is the minimal compression pressure to improve venous pumping<br />
function in patients with venous insufficiency?<br />
GE1.7-6 A. Cornu-Thénard: Hemodynamic effects of medical compression stockings in<br />
varicose veins<br />
GE1.7-7 D. Milic: The influence of different interface pressure values on venous leg ulcers<br />
healing when treated with compression therapy<br />
GE1.7-8 S. Reich-Schupke: The resting pressure exerted by round knitted moderate<br />
compression stockings on the lower leg in clinical practice - results of an<br />
experimental study<br />
GE1.7-9 F. Chleir: Is the pression of compressotherapy after a deep venous thrombosis<br />
influence the importance of the post-thrombotic syndrome?<br />
GE1.7-10 C. Lim: A summation analysis of compliance and complications with compression<br />
hosiery for chronic venous disorders<br />
GE1.7-11 G. Mosti: MRI shows narrowing of leg veins by compression depending on exerted<br />
pressure and body position<br />
GE1.7-12 F. Vin: Observational study of the venous disease evolution during pregnancy with<br />
or without class 2 compression stockings<br />
14.30-15.15<br />
Camille Blanc Pierre Fabre Symposium (first part) (CB1.8)<br />
Venous ulcer: the final stage in chronic venous disease - Managing it in <strong>2009</strong><br />
Chairperson: Patrick Carpentier<br />
CB1.8-1 A. Nicolaides: From pathophysiology to clinical evaluation<br />
CB1.8-2 P. Blanchemaison: Therapeutic Management of venous ulcer<br />
15.30-16.15<br />
Camille Blanc Pierre Fabre Symposium (second part) (CB1.9)<br />
Compression therapy: new device<br />
Chairperson: H. Partsch<br />
CB1.9-1 I. Quéré<br />
15.30-17.30<br />
Scotto Session of the Latin American Chapter (SC1.9)<br />
The Varicose syndrome: The Latin America overview of the Diagnosis<br />
and Management<br />
Chairpersons: A. Scuderi, E. Altmann Canestri, R. Simkin<br />
SC1.9-1 N. Rosli: Foam: State of the art in Argentina<br />
SC1.9-2 A. Shapira: Management of the superficial venous insufficiency in <strong>2009</strong><br />
An overview<br />
SC1.9-3 J. Ulloa: Poor stability of Polidocanol foam as compared with<br />
Lapidium Cloridrate
SC1.9-4 F. Flota Cervera: The prevalence of Lymphoedema in Primary Varicose Disease<br />
and the efficacy of Calcium Dobesilate on the resolution of lymphatic edema<br />
SC1.9-5 V. Canata: Varicose veins disease overview of treatment in Paraguay<br />
SC1.9-6 V. Ibañez Esquembre: Inclusion and exclusion criteria of the endo laser<br />
management of the varicose syndrome<br />
SC1.9-7 R. Varnagy: Surgery of Varicose Veins. The History of the “pop star”<br />
SC1.9-8 M. Bravo: Prophylaxis of DVT in surgery<br />
16.00-16.30 Coffee break in Exhibition hall<br />
16.30-17.15<br />
Apollinaire Max Ratschow Medal Session (Collegium Internationalis Angiologiae) (AP1.10)<br />
Chairperson: E. Rabe<br />
AP1.10-1 J.L. Villavicencio: Pelvic venous disorders: the desperate plea of women<br />
with the nutcracker syndrome<br />
Laudatio by E. Rabe<br />
16.30-18.30<br />
Prince Pierre Free Paper Session: Endovenous Procedures 2 - Comparative Studies (PP1.11)<br />
Chairperson: S. Schuller-Petrovic<br />
Moderator: F. Pannier<br />
PP1.11-1 R. Kikuchi: Clinical comparison of radiofrequency ablation (RFA) versus<br />
endovenous laser ablation (EVLA) in great saphenous vein insufficiency treatment<br />
PP1.11-2 R. Gonzalez: Endovenous laser and echo-guided foam<br />
MONDAY, AUGUST 31 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
PP1.11-3 L. Kabnick: 980nm laser vs. radiofrequency for endothermal venous ablation<br />
of the GSV: are the recovery results similiar?<br />
PP1.11-4 J. Christenson: Prospective randomized trial comparing endovenous laser ablation<br />
and surgery for treatment of primary great saphenous varicose veins-<br />
2 years follow up<br />
PP1.11-5 J. Ragg: Comparison of radiofrequency and laser treatment in saphenous veins<br />
PP1.11-6 M. Mooijj: Randomized clinical trial of endovenous laser ablation (980 nm)<br />
versus high ligation combined with stripping of the great saphenous vein<br />
with tumescent anaesthesia<br />
PP1.11-7 K. Rass: Endovenous laser ablation versus high ligation and stripping of the great<br />
saphenous vein: 2 year results of the relacs study<br />
PP1.11-8 J. Tesmann: Bipolar radiofrequency obliteration of varicose veins compared to<br />
endovenous laser treatment: a prospective study emphasizing on occlusion<br />
rates, side-effects and stability of the resulting stump<br />
Camille Blanc ICC Symposium: New methods to evaluate compression therapy (CB1.11)<br />
Chairperson: H. Partsch<br />
Moderator: R. Damstra<br />
CB1.11-1 H. Partsch: Measurement of interface pressure<br />
CB1.11-2 J.P. Benigni: Friction index of medical compression stockings<br />
CB1.11-3 R. Damstra: Compression pressure in lymphoedema of the upper<br />
and lower extremitites<br />
CB1.11-4 J.F. Uhl: 3 D-CT for demonstrating compression effects<br />
CB1.11-5 F. Lurie: MRI for detecting hemodynamic effects of intermittent pneumatic<br />
compression<br />
CB1.11-6 G. Mosti: Haemodynamic effects of compression depending on interface pressure<br />
CB1.11-7 M. Jünger: Dermal microcirculation in Chronic Venous Insufficiency (CVI)<br />
and peripheral arterial occlusive disease: change of dermal fluxmotion<br />
by compression bandages<br />
CB1.11-8 E. Rabe: Does Compression influence progression of venous diseases?<br />
13
14<br />
MONDAY, AUGUST 31 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
Bosio Session of the Asian and Australasian Chapter (BO1.11)<br />
16.30-18.30 Chairpersons: B.B. Lee, M. Malouf<br />
BO1.11-1 T. Yamaki: High peak reflux velocity in the proximal deep veins is a strong<br />
predictor of advanced postthrombotic sequelae<br />
BO.1.11-2 T. Ogawa: Relation between radiofrequency and laser ablated venous diameter<br />
and recanalization<br />
BO1.11-3 K.T Kim: The current management of varicose vein surgery for leg vein in Korea<br />
BO1.11-4 Y. Gu: Surgical treatment of severe acute deep venous thrombosis in lower<br />
extremity<br />
BO1.11-5 M. Patel: Helps and hinderances to the diagnosis and treatment of venous<br />
disease in India<br />
BO1.11-6 K. Parsi: Interactions of sclerosants with the coagulation system<br />
BO1.11-7 N. Piller: Early detection of subtle (pre-clinical) fluid changes in legs using<br />
Bioimpedance Spectroscopy<br />
BO1.11-8 J. Barrett: The natural history of thrombosis in the proximal non-lasered<br />
saphenous vein segment following EVLA<br />
Genevoix Free Paper Session: Venous Anatomy and Epidemiology (GE1.11)<br />
16.30-18.30 Chairperson: S. Ricci<br />
Moderator: A. Caggiati<br />
GE1.11-1 A. Zanon: Brief historical excursus on the discovery of the blood circulation<br />
GE1.11-2 G. Schweighofer: The thigh extension - from Giacomini’s observation to clinical<br />
anatomy of the present<br />
GE1.11-3 C. Tasch: The ostial valve of the great saphenous vein<br />
GE1.11-4 M. Vakhitov: Anatomic causes of the varicose vein disease development in lower<br />
extremities<br />
GE1.11-5 A. Van Rij: Venous Perforators in normal lower limbs - Ultrasound characterisation<br />
and comparison with resin caste anatomy<br />
GE1.11-6 S. Ricci: Echographic sural nerve visualisation: method and anatomical aspects<br />
GE1.11-7 P. Carpentier: Risk factors for incident chronic venous disorders: results from<br />
the basel follow-up study<br />
GE1.11-8 M. Lefebvre-Villardebo: Prevalence of perineal varices in varicose disease<br />
of lower limbs<br />
GE1.11-9 V. Stvrtinova: How to improve the awareness of chronic venous disease -<br />
an experience from Slovak Republic<br />
GE1.11-10 J.F. Uhl: Anatomical variations of the femoral vein above the knee<br />
GE1.11-11 J. Nigro: Hemodynamic study of the reflux circuit in great saphenous vein in the<br />
essential venous insufficiency<br />
GE1.11.12 A. Kokkosis: The distribution and significance of varicosities in the saphenous<br />
trunks<br />
17.15-18.30<br />
Apollinaire Free Paper Session: Venous Malformation (AP1.12)<br />
Chairperson: J.L. Villavicencio<br />
Moderator: D. Loose<br />
AP1.12-1 Z. Maksimovic: Varicose venous disease caused by congenital vascular<br />
malformations<br />
AP1.12-2 R. Mattassi: Venous malformations are often coupled with lymphatic dysplasias<br />
AP1.12-3 S. Sapelkin: Magnetic resonance imaging in diagnostic of vascular malformations<br />
AP1.12-4 L. Corcos: The role of diode 808 nm endovenous laser in the treatment<br />
of congenital venous malformations<br />
AP1.12-5 A. Sierra: Safety of ultrasound guided microfoam sclerotherapy (UGMS) in children<br />
with venous malformations<br />
AP1.12-6 R. Malgor: Surgical treatment of venous malformations in Klippel-Trénaunay<br />
Syndrome (KTS)
S C I E N T I F I C P R O G R A M M E<br />
Tuesday, September 1 st<br />
07.30-08.45<br />
Apollinaire Talk to the experts (AP2.1)<br />
O. Maleti: The Neovalve in PTS - tips and tricks<br />
M. Perrin: discussant moderator<br />
Bosio Talk to the experts (BO2.1)<br />
H. Partsch: My technique in compression treatment - bandages or stockings<br />
G. Mosti: discussant moderator<br />
Genevoix Talk to the experts (GE2.1)<br />
M. Goldman: Esthetic treatments and phlebology practice<br />
M. Malouf: discussant moderator<br />
08.45-09.00 Coffee break in Exhibition hall<br />
09.00-11.00<br />
Prince Pierre Thromboembolic Disease (PP2.2)<br />
Chairperson: W. Blättler<br />
Moderator: M. Meissner<br />
PP2.2-1 A. Comerota: Current status of thrombolysis and thrombectomy in iliofemoral DVT<br />
PP2.2-2 N. Baekgaard: Catheter directed thrombolysis in iliofemoral DVT<br />
PP2.2-3 S. Vedantham: Endovascular DVT interventions<br />
PP2.2-4 H. Décousus: New anticoagulants in the treatment of venous thromboembolism<br />
PP2.2-5 J. Lohr: Calf vein thrombosis - how to treat<br />
PP2.2-6 R. Bauersachs et al: TULIPA registry - recent practice in diagnosis<br />
and treatment of DVT<br />
PP2.2-7 B. Eklöf: Anything new in travel related venous thromboembolism?<br />
PP2.2-8 M. de Maeseneer: How to treat superficial thrombophlebitis?<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
11.00-11.30 Coffee break in Exhibition hall<br />
11.30-12.00<br />
Prince Pierre Guest lecture (PP2.3)<br />
Chairperson: M. Malouf<br />
N. Labropoulos: Why do varicose veins develop?<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
12.00-13.00<br />
Prince Pierre <strong>UIP</strong> Consensus Varicose Veins (PP2.4)<br />
Chairpersons: P. Gloviczki, H. Neumann<br />
PP2.4-1 P. Gloviczki: <strong>UIP</strong> consensus on diagnosis and treatment of varicose veins<br />
PP2.4-2 M. de Maeseneer: Classification of duplex findings after treatment of saphenous<br />
varicose veins<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
13.00-14.00<br />
Apollinaire Session of the German Society of Phlebology (AP2.5)<br />
Board Meeting (by invitation only)<br />
15
16<br />
TUESDAY, SEPTEMBER 1 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
Bosio VNUS workshop (BO2.5)<br />
13.00-14.00 Chairpersons: T. Proebstle, M. Vasquez<br />
BO2.5-1 J. Alm: Small Saphenous Veins with ClosureFAST<br />
BO2.5-2 T. Proebstle: ClosureFAST, 3 years follow up<br />
BO2.5-3 M. Vasquez: Perforators with the VNUS RFS catheters<br />
BO2.5-4 O. Goeckeritz: Closure vs. Laser (Recovery Study)<br />
BO2.5-5 T. Proebstle: Hands On (Tissue Interaction)<br />
14.00-15.00<br />
Presentation of posters by authors: posters DIA 17 to 31<br />
Chairpersons: M. Schadeck, H. Gerlach<br />
Discussants: T.Yamaki, M. Dalsing<br />
14.00-15.30<br />
Camille Blanc Servier Symposium: Management of chronic venous disease:<br />
therapeutic recommendations (CB2.6)<br />
Chairpersons: A.N. Nicolaides, E. Rabe<br />
E. Rabe: Introduction<br />
CB2.6-1 A. Comerota: What’s new in guidelines?<br />
CB2.6-2 A.A. Ramelet: Management of chronic venous disease: the example of Daflon 500mg<br />
CB2.6-3 A. Jawien: Unmet needs in assessment of symptoms and signs<br />
CB2.6-4 A.N. Nicolaides: Recent guidelines in chronic venous disease:<br />
the place of Daflon 500 mg<br />
A.N. Nicolaides: Conclusion<br />
14.00-16.00<br />
Prince Pierre Free Paper Session: Sclerotherapy 2 - Miscellaneous (PP2.6)<br />
Chairperson: C. Hamel-Desnos<br />
Moderator: A. Cavezzi<br />
PP2.6-1 M. Lefebvre-Vilardebo: Intra-operative sclerotherapy of post-surgical inguinal<br />
neovascularization: 2 years results<br />
PP2.6-2 F. Zini: Surgery or sclerotherapy for groin recurrent varicose veins?<br />
PP2.6-3 E. Ivanov: A comparison of sclerotherapy modifications in the treatment of venous<br />
stasis dermatitis<br />
PP2.6-4 N. Bunke: Non-saphenous sclerofoam treatment of lower extremity<br />
primary varicose veins<br />
PP2.6-5 M. Stücker: Efficiency and safety of an accelerated therapy regime for tributaries:<br />
polidocanol-0,5%-foam with injections every 2 nd to 3 rd day<br />
PP2.6-6 P. Antignani: The role of foam sclerotherapy in ederly patient (over70) with severe<br />
disabling CVI<br />
PP2.6-7 H. Bernbach: Compression in sclerotherapy of the sapheno-femoral junction:<br />
our experience<br />
PP2.6-8 L. Moro: CO2 foam sclerotherapy in patients over 70 years old: efficacy and safety<br />
PP2.6-9 J.De Abajo Fernandez: Sequential sclerosant treatment of varices in lower limbs<br />
secondary to pelvic venous desease<br />
PP2.6-10 N. Haruta: Significance of severing insufficient perforating veins in the treatment<br />
of varicose veins by sclerotherapy, subtitle: condition of insufficient perforating<br />
veins after sclerotherapy<br />
PP2.6-11 J. Klode: Polidocanol foam sclerotherapy as a new and effective treatment of post<br />
surgical lymphocutaneous fistula: first results of a clinical trial<br />
PP2.6-12 J. Ulloa: Hand veins: new approach with lapidium clorhidrate foam
S C I E N T I F I C P R O G R A M M E<br />
TUESDAY, SEPTEMBER 1 ST<br />
Apollinaire Free Paper Session: Endovenous Procedures 3 - Prospective Studies (AP2.6)<br />
14.00-16.00 Chairperson: S. Zimmet<br />
Moderator: L. Kabnick<br />
AP2.6-1 P. Chapman-Smith: Endovenous laser ablation (EVLA) with 1320nm in<br />
the treatment of varicose veins - a 3 years prospective study<br />
AP2.6-2 F. Vin: Endovenous laser treatment of greater saphenous veins. Results at 2 years<br />
AP2.6-3 G. Agus: Endovenous laser treatment of saphenous and perforators reflux for leg<br />
ulcers in primary chronic venous insufficiency<br />
AP2.6-4 T. King: Experience with concomitant ultrasound-guided foam sclerotherapy<br />
and endovenous laser treatment in chronic venous disorder and its influence<br />
on Health Related Quality of Life (HRQL): interim analysis of more than 1000<br />
consecutive procedures<br />
AP2.6-5 S. Mancini: Endovenous laser treatment of varicose veins. Results to 5 years<br />
AP2.6-6 S. Jianu: Endovenous laser treatment versus surgery for incompetent great and<br />
small saphenous veins<br />
AP2.6-7 S. Kaspar: Six years experience with endovenous laser ablation in Czech Republic<br />
AP2.6-8 I. Kabnick: 1010 980nm laser saphenous ablations with 12-24 months duplex<br />
examination<br />
AP2.6-9 T. King: Progression and recurrence of vein disease in patients treated with<br />
endovenous laser ablation: two-four year experience. Is there a place for<br />
the phrase recurrent varices after laser or reval?<br />
AP2.6-10 R. Kikuchi: Clinical comparison of thigh only versus extended endovenous laser<br />
ablation (EVLA) in great saphenous vein insufficiency treatment<br />
AP2.6-11 C. Stuckey: Incompetent perforators - the unseen villain<br />
AP2.6-12 S. Vayuvegula: early results of the new 1470nm radial fiber on truncal reflux using<br />
only 3W of energy delivery<br />
Bosio Session of the German Society of Phlebology<br />
14.00-16.00 Varicose Veins and Venous Ulcers (BO2.6)<br />
Chairperson: H. Gerlach<br />
Moderator: H. Kluess<br />
BO2.6-1 A. Ladwig: Prevalence of chronic venous insufficiency in the population<br />
of north-east Germany (study of health in Pomerania)<br />
BO2.6-2 E. Rabe et Al: Incidence of varicose veins and CVI in the Bonn vein study II<br />
BO2.6-3 H. Kluess: German guidelines for diagnosis and treatment of varicose vein disease<br />
BO2.6-5 N. Frings: Venous surgery in very old patients (> 70 years)<br />
BO2.6-6 G. Gallenkemper: German guidelines on diagnosis and treatment of venous ulcers<br />
BO2.6-7 A. Obermayer: A “sourcing” for the responsible venous reflux causing leg ulcers<br />
BO2.6-8 A. Obermayer: Venous reflux surgery promotes venous leg ulcer healing despite<br />
reduced ABPI<br />
BO2.6-9 H. Hermanns: Ulcer surgery and very old patients (80 -100 years)<br />
- a practical procedure?<br />
BO2.6-10 W. Blättler, D. Lüscher, E.O. Brizzio, F. Amsler, T. Willenberg: Healing of venous<br />
ulcers is determined in part by genetic polymorphisms of factor XIII and iron<br />
metabolism<br />
Genevoix Short free paper Session I (GE2.6)<br />
14.00-16.00 Chairperson: A. Mansilha<br />
Moderator: P. Coleridge-Smith<br />
GE2.6-1 M. Goldman: Long term follow-up study of intravascular 1320-nm laser closure<br />
of the great saphenous vein<br />
GE2.6-2 M. Goldman: Efficacy of additional graduated compression after sclerotherapy<br />
treatment of reticular and telangiectatic leg veins<br />
GE2.6-3 M.Goldman: Complications of foam sclerotherapy for reticular veins<br />
GE2.6-4 A. Cornu-Thénard: A CA and CB for each C class of the C of CEAP classification<br />
17
18<br />
TUESDAY, SEPTEMBER 1 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
GE2.6-5 M. Cazaubon: The CEAP classification in daily phlebology practice: a Franco-Italian<br />
multicenter survey on the prevalence of isolated varices (C2) and complicated<br />
varices (C2+)<br />
GE2.6-6 R.F. Vega: Prevalence of varicose veins in a diagnostic unit in Mexico City<br />
GE2.6-7 S. Sadoun: Epidemiological study of the seasonnal variation of the incidence<br />
and the prevalence of venous ulcer: the Vesuve study (variation epidémiologique<br />
saisonnière de l’ulcère d’origine veineuse)<br />
GE2.6-8 E. Bernardini: Evolution of primary venous insufficiency: ascending development.<br />
Observational and hemodynamic study<br />
GE2.6-9 V. Ivan: Posterior accessory saphenous vein of the leg: implications in the<br />
pathogenic sever trophic disorders<br />
GE2.6-10 J. Nigro: Hemodynamic study of the reflux circuit in short saphenous vein in the<br />
essential venous insufficiency<br />
GE2.6-11 E. Brizzio: Internal Calf Pump Performance (ICP) evaluated togheter with<br />
ecodoppler color<br />
GE2.6-12 F. Van Sprundel: Pseudo-phlegmasia caerulea dolens after cardiac catheterization<br />
GE2.6-13 N. Morrison: Relationship between number of pregnancies and great saphenous<br />
vein diameter<br />
GE2.6-14 I. Zhang: The research of erythrocytes immune function in chronic venous<br />
insufficiency of the lower extremities<br />
GE2.6-15 M. Griffin: The challenges associated with venous duplex scanning<br />
GE2.6-16 N. Piller: Differential diagnosis: what if the swelling is lymphoedema, lipoedema or<br />
myxoedema?<br />
GE2.6-17 K. Hartmann: Treatment of incomplete trunk varicosity with combined foam<br />
sclerotherapy and vnus closure fast technique<br />
GE2.6-18 E. Menegatti: Echo-color doppler criteria for diagnosis of chronic cerebrospinal<br />
venous insufficiency<br />
GE2.6-20 A. Cornu-Thénard: International phlebological file , or how to make CEAP friendly<br />
and easy to use<br />
GE2.6-21 P. Bhaskaran: Assessment of microcirculation on sternal wound healing after open<br />
chest cardiac surgery using laser doppler imaging system<br />
GE2.6-22 P. Bhaskaran: Clinical use of laser doppler scanner as a diagnostic and prognostic<br />
tool for peripheral vascular disease<br />
GE2.6-23 S. Sadoun: Treatment for panniculitis, using mesotherapy : a study of 10<br />
consecutive patients<br />
15.30-16.00<br />
Camille Blanc Lecture (CB2.7)<br />
Chairperson: A. Scuderi<br />
C. Allegra: Microcirculation in Phlebology<br />
16.00-16.30 Coffee break in Exhibition hall<br />
16.30-18.30<br />
Prince Pierre Free Paper Session: Sclerotherapy 3 - Safety aspects (PP2.8)<br />
Chairperson: M. Schadeck<br />
Moderator: K. Hartmann<br />
PP2.8-1 J.J. Guex: The French polidocanol registry on long term side effects -<br />
a survey covering 3357 patient years<br />
PP2.8-2 M. Schadeck: Complications of duplex guided sclerotherapy of the small<br />
saphenous vein. Study of a population of 4984 patients<br />
PP2.8-3 K. Parsi: Detergent sclerosants interfere with natural fibrinolytic mechanisms but<br />
induce clot lysis in vitro
S C I E N T I F I C P R O G R A M M E<br />
TUESDAY, SEPTEMBER 1 ST<br />
PP2.8-4 C. Hamel-Desnos: Sclerotherapy of varicose veins in patients with documented<br />
thrombophilia. A prospective controlled randomized study of 105 cases<br />
PP2.8-5 P. Thibault: Perivenous tumescent compression to enhance sclerotherapy results<br />
and reduce adverse effects<br />
PP2.8-6 L.Tessari: May sclerotherapy cause a pulmonary injury? Preliminary results with<br />
dynamic scans of the thorax using 99mtc pertecnethate<br />
PP2.8-7 D. Wright: Polidocanol does not remain on the surface of bubbles free in the<br />
venous blood<br />
PP2.8-8 A. Cornu-Thénard: Foam Echoguided Sclerotherapy (FES): how to avoid overdoses<br />
before injections?<br />
PP2.8-9 D. Wright: Prevalence of patent foramen ovale (right to left shunt) is higher<br />
in patients with varicose veins<br />
PP2.8-10 L. Tessari: Chasing the bubbles in foam sclerotherapy<br />
PP2.8-11 P. Raymond-Martimbeau: Transient adverse effects positively associated with<br />
patent foramen ovale after ultrasound-guided foam sclerotherapy<br />
Camille Blanc Free Paper Session: Venous Pathophysiology (CB2.8)<br />
16.30-18.30 Chairperson: M. Rosenblatt<br />
Moderator: F. Boccardo<br />
CB2.8-1 F. Chleir: Modification of long saphenous vein diameter during pregnancy<br />
CB2.8-2 F. Passariello: The role of circumflex femoral veins in the SFJ incompetence.<br />
A case report<br />
CB2.8-3 T. Iwai: Popliteal vein symptomatic & asymptomatic entrapment, and popliteal vein<br />
thrombosis caused by vein entrapment with or without soleus muscle vein dilatation<br />
CB2.8-4 A.C. Shepherd: Anatomical reflux does not predict the functional impact of venous<br />
disease<br />
CB2.8-5 L. Moro: Early stages of venous disease are associated with arterial endothelial<br />
dysfunction in healthy adults<br />
CB2.8-6 M. Cappelli: The pathophysiological role of extra-saphenic perforator veins<br />
CB2.8-7 A. Vital: Unmyelinated C fibers and inflammatory cells are present in the wall of<br />
human varicose veins. A clinico-pathological study<br />
CB2.8-8 S. Schulz: Venous flow pattern and heart disease<br />
CB2.8-9 B. Kahle: Non-invasive bioengineering assessment of the skin barrier function in<br />
patients with chronic venous insufficiency<br />
CB2.8-10 G. Jones: Conscious venous blood pressure measurements in a porcine model of<br />
superficial varicose veins<br />
CB2.8-11 A. Van Rij: Proteomic comparison of varicose veins in humans and in those that<br />
develop in a new porcine model<br />
CB2.8-12 Y. Herouy: Angiogenesis and venous insufficiency<br />
Apollinaire Free Paper Session: Endovenous Procedures 4 - Wavelength and new Fibres (AP2.8)<br />
16.30-18.30 Chairperson: N. Morrison<br />
Moderator: M. Stuecker<br />
AP2.8-1 A Sanchez-Galan: Does the wavelength influence the results when treating internal<br />
saphenous vein insufficiency with endovenous laser treatment? A prospective<br />
analysis comparing three series<br />
AP2.8-2 S. Kaspar: Laser wavelength and its influence on outcome of endovenous ablation<br />
of varicose veins<br />
AP2.8-3 J. Ferreira: Endovascular vein ablation using a 1470 diode laser and radial fibers -<br />
a new era is arising?<br />
AP2.8-4 S. Shokoku: Treatment of the varicose veins using 1470nm diode laser - short<br />
term results<br />
19
20<br />
TUESDAY, SEPTEMBER 1 ST<br />
S C I E N T I F I C P R O G R A M M E<br />
AP2.8-5 F. Pannier: Endovenous Laser Ablation (EVLA) of the GSV with a 1470 nm diode<br />
laser and a radial emitting fiber. Follow-up after 6 month and comparison with the<br />
bare fibre<br />
AP2.8-6 J. Soracco: Endovenous laser treatment with 1470nm laser and external<br />
chromophore. Preliminary study<br />
AP2.8-7 A. Hoch: Effectiveness and clinical outcome following endovenous therapy<br />
of primary varicose veins: first results of a randomised, prospective study<br />
comparing the vnus closure fast system, 980nm and 1470nm lasers and<br />
conventional surgery<br />
AP2.8-8 U. Maurins: Does the laser power influence the results of Endovenous Laser<br />
Ablation (EVLA) of incompetent saphenous veins with the 1470 nm diode laser<br />
and radial fiber - a prospective randomized study comparing 10 and 15 watt. 5<br />
months follow-up<br />
AP2.8-9 M. Vuylsteke: Endovenous laser ablation: intraluminal centralisation of fibre-tip can<br />
perfectionate the technique, a histological study<br />
AP2.8-10 M. Vuylsteke: Endovenous laser treatment: is there a clinical difference using a 1500nm<br />
laser versus a 980nm diode laser? A multicentric prospective comparative trial<br />
AP2.8-11 J. Ragg: Comparison of 810 to 1470 nm laser systems in identical veins<br />
AP2.8-12 L. Corcos: The past, present and future of 808 nm diode laser in the treatment of<br />
varicose veins of the lower limbs<br />
Bosio Session of the German Society of Phlebology<br />
16.30-18.30 Endovenous treatment: Obesity and CVI (BO2.8)<br />
Chairperson: A.A. Ramelet<br />
Moderator: S. Schuller Petrovic<br />
BO2.8-1 A.A Ramelet: Polidocanol - rare adverse effects<br />
BO2.8-2 S. Schuller Petrovic: Tissue effects after subcutaneous injection with foam or liquid<br />
Polidocanol<br />
BO2.8-3 C. Jeanneret: The Swiss registry of thermic endovenous catheter interventions in<br />
varicose veins, a multicenter case control study<br />
BO2.8-4 I. Flessenkämper, M. Hartmann, D. Stenger: RCT for differentiated open and<br />
endoluminal therapies for degenerative disease of the great saphenous veins<br />
BO2.8-5 K. Göstl: Obesity: a risk factor for CVI?<br />
BO2.8-6 J. Christenson: Relationship between body mass index and the severity<br />
of chronic primary venous disease<br />
BO2.8-7 H. Hermanns: Obesity and varicose vein surgery<br />
BO2.8-8 H. Hermanns: Varicose vein surgery and obesity - experience with a new boazul<br />
cuff in leg circumference up to 90 cm<br />
BO2.8-9 J. Herouy: Leg comparison of region, gender and age in Germany by digital<br />
3D-measurements to venous diagnosis<br />
Genevoix Free Paper Session: Venous Diagnosis 1 (GE2.8)<br />
16.30-18.30 Chairperson: G. Gallenkemper<br />
Moderator: E. Brizzio<br />
GE2.8-1 D. Milic: Risk factors related to the failure of venous leg ulcers to heal with<br />
compression treatment<br />
GE2.8-2 J.F. Uhl: New virtual computer tools to investige venous patients<br />
GE2.8-3 K. Miyake: Superficial venous score 9-1: A classification system that improves<br />
cosmetic treatment of leg vein lesions<br />
GE2.8-4 S. Reeder: The relation between CEAP and the gold standard ambulatory venous<br />
pressure measurement.
S C I E N T I F I C P R O G R A M M E<br />
GE2.8-5 J.F. Uhl: The static disorders of the foot: a major risk factor of CVI<br />
GE2.8-6 C. Blazek: Several dermatological applications of functional skin microcirculation<br />
mapping using PPGI method<br />
GE2.8.7 V. Blazek: Space-resolved low frequency blood volume rhythms in skin perfusion<br />
obtained by camera based optical sensing (photoplethysmography imaging)<br />
GE2.8-8 G. Avruscio: A new method for studying Chronic Venous Insufficiency (CVI):<br />
Telemetric Light Reflex Rheography (TLRR).<br />
GE2.8-9 R. Di Stefano: Dynamic foot – exerciser: a validation study and testing in disuse<br />
oedema patients<br />
GE2.8-10 T. Yamaki: Increased calf muscle deoxygenation during light-intensity exercise<br />
suggests increased venous reflux flow in advanced human chronic venous<br />
disease<br />
GE2.8-11 M. Pejic: The incidence of deep vein thrombosis in patients undergoing<br />
laparoscopic procedures<br />
20.00<br />
Sporting Montecarlo, Salle des Etoiles<br />
<strong>UIP</strong> 50 th Anniversary Gala dinner (ticketed event)<br />
Shuttle bus will be provided from the hotels.<br />
TUESDAY, SEPTEMBER 1 ST<br />
21
22<br />
S C I E N T I F I C P R O G R A M M E<br />
Wednesday, September 2 nd<br />
07.30-08.45<br />
Apollinaire Talk to the experts (AP3.1)<br />
J.F. Uhl: 3D-imaging of the venous system<br />
A. Caggiati: discussant moderator<br />
Bosio Talk to the experts (BO3.1)<br />
T. Proebstle: Closure Fast ® , indications and how to do it<br />
N. Morrison: discussant moderator<br />
Genevoix Talk to the experts (GE3.1)<br />
N. Labropoulos: Duplex of the deep veins - tips and tricks<br />
D. Neuhardt: discussant moderator<br />
08.45-09.00 Coffee break in Exhibition hall<br />
09.00-09.45<br />
Prince Pierre Special issue in Phlebology (PP3.2)<br />
Chaiperson: J. Cabrera<br />
Moderator: A. Ramelet<br />
PP3.2-1 A.Frullini: Enhanced sclerosis by vis-sclerotherapy: a new treatment of superficial<br />
venous insufficiency<br />
PP3.2-2 S. Elias: A new pharmacomechanical method of endovenous ablation: Clarivein®<br />
PP3.2-3 F. Chleir: Aged degenerating macula and eyes venous insufficiency<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
09.45-11.00<br />
Prince Pierre Chronic Cerebro-Spinal Venous Insufficiency (CCSVI):<br />
diagnosis and treatment (PP3.3)<br />
Chairperson : P. Zamboni<br />
Moderator: B.B. Lee<br />
PP3.3-1 M Simka: CCSVI and Multiple Sclerosis: theoretical and practical issues<br />
PP3.3-2 M. Haacke: Cerebral veins and iron deposits explored by advanced MRI-SWI<br />
PP3.3-3 R. Galeotti: Imaging and endovascular treatment of CCSVI<br />
PP3.3-4 F. Salvi: Treatment of CCSVI: clinical results on associated multiple sclerosis<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
11.00-11.30 Coffee break in Exhibition hall<br />
11.30-12.00<br />
Prince Pierre Guest lecture (PP3.4)<br />
Chairperson : M. de Maeseneer<br />
W. Blättler: Asymptomatic deep venous thrombosis<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
12.00-13.00<br />
Prince Pierre <strong>UIP</strong> Consensus Curriculum in Phlebology (PP3.5 )<br />
Chairperson: S. Raju<br />
Moderator: K. Parsi<br />
PP3.5-1 K. Parsi: Curriculum in Phlebology (<strong>UIP</strong> consensus)<br />
PP3.5-2 F. Lurie: <strong>UIP</strong> consensus on diagnosis and treatment of deep venous insufficiency
S C I E N T I F I C P R O G R A M M E<br />
PP3.5-3 E. Rabe, R. Bauersachs, F. Pannier: DAPS - Dalteparin in patients with Superficial<br />
Leg Vein Phlebitis (SVP) in addition to compression treatment - a placebocontrolled<br />
phase III study<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
13.00-14.00<br />
Apollinaire Session of the German Society of Phlebology (AP3.6)<br />
Bauerfeind Award<br />
Hartmann Price<br />
13.00-15.00<br />
Auric Council meeting (by invitation: presidents of member societies and board members)<br />
14.00-15.00<br />
Presentation of posters by authors DIA 32 to 46<br />
Chairpersons: M. Schadeck, H. Gerlach<br />
Discussants: S. Simkin, G. Agus<br />
WEDNESDAY, SEPTEMBER 2 nd<br />
14.00-16.00<br />
Prince Pierre Medi Symposium (PP3.7)<br />
Compression therapy after surgery and endovenous procedures<br />
Chairperson: H. Partsch<br />
PP3.7-1 E. Rabe: What is the rationale for post-procedural compression?<br />
PP3.7-2 P. Coleridge Smith: What is the evidence?<br />
PP3.7-3 N. Morrison: Different forms of compression after different procedures?<br />
PP3.7-4 S. Zimmet: How I do it<br />
PP3.7-5 M. Neumann: Requirements of compression garments in the post-procedural<br />
management<br />
PP3.7-6 JP Benigni: A new compression device<br />
PP3.7-7 M. Lugli: What is the rationale for the crossed-tape technique?<br />
PP3.7-8 G. Mosti: Comparison of three different forms of compression after varicose vein<br />
surgery<br />
Camille Blanc Free Paper Session: Endovenous Procedures 5: RFA (CB3.7)<br />
Chairperson: T. Proebstle<br />
Moderator: O. Pichot<br />
CB3.7-1 R.Weiss: Ten year experience with endovenous ablation: RF and laser<br />
CB3.7-2 T. Proebstle: Radiofrequency Segmental Thermal Ablation (RSTA) of great<br />
saphenous veins: two year follow-up<br />
CB3.7-3 T. Noppeney: Metaanalysis of the results after radiofrequency obliteration for<br />
treatment of varicosis<br />
CB3.7-4 K. Brachmann: Histological changes after endovenous radiofrequency therapie<br />
(VNUS closure/ closure fast)<br />
CB3.7-5 J. Alm: Closure fast. A novel concept of endovenous thermal ablation for short<br />
saphenous veins. Techniques and initial clinical experience<br />
CB3.7-6 M. Stücker: The extent of necrosis of the vein-wall is determined by power and<br />
time of the applied bipolar radiofrequency-induced thermotherapy - histological<br />
results of an ex-vivo experiment<br />
CB3.7-7 S. Ray: The role of endovenous ablation in the treatment of recurrent varicose<br />
veins<br />
23
24<br />
WEDNESDAY, SEPTEMBER 2 nd<br />
S C I E N T I F I C P R O G R A M M E<br />
CB3.7-8 A. Shepherd: Radiofrequency ablation or endovenous laser therapy for varicose<br />
veins?<br />
CB3.7-9 L. Hnatek: Two years experience and one year follow-up results with<br />
radiofrequency induced thermotherapy (RFITT) of varicose veins<br />
CB3.7-10 J. Alm: Recurrence varicosis of Greater Saphenous Vein (GSV) after endovenous<br />
radiofrequency (RF) ablation - retreatment and comparison with RFITT<br />
CB3.7-11 L. Hnatek: Endovascular radiofrequency induced thermo-therapy (RFITT) for the<br />
treatment of perforating veins<br />
Apollinaire Free Paper Session: Sclerotherapy 4: Telangiectases and reticular veins (AP3.7)<br />
14.00-16.00 Chairperson: S. Küpfer<br />
Moderator: J. Barrett<br />
AP3.7-1 J.C.M. Chardonneau: Telangiectasias microsclerotherapy treatment: the rules of 3<br />
AP3.7-2 B. Kahle: Efficacy of sclerotherapy in intradermal varicose veins - a prospective,<br />
double blinded, placebocontrolled study<br />
AP3.7-3 E. Rabe: Polidocanol, sodium tetradecyl sulfate and placebo for sclerotherapy of<br />
C1-varicose veins: a double-blind, randomized, controlled clinical trial (EASI-Study)<br />
AP3.7-4 D. Schliephake: A new standardized digital imaging system to document treatment<br />
success after sclerotherapy of C1-varicose veins applied in a double-blind,<br />
randomized, controlled clinical trial (EASI-Study)<br />
AP3.7-5 J. Zhang : Polidocanol/lauromacrogol 400 vs. placebo for sclerotherapy of C1 and<br />
C2 non-saphenous trunk varicose veins: a double-blind, randomized, controlled,<br />
multi-center clinical trial (esachina study) performed in the P.R. of China<br />
AP3.7-6 R. Weiss: 24 year retrospective review of safety and efficacy of STS and POL for<br />
treatment of telangiectasias and reticular veins<br />
AP3.7-7 G.Bruning: More efficiency through transillumiunation with Veinlite® in<br />
the sclerotherapie of spider veins<br />
AP3.7-8 J. Ferreira: Laser Enhanced Sclerotherapy (LES) treatment of telangiectasias<br />
AP3.7-9 M. Schul: Compression therapy vs. sclerotherapy for isolated refluxing reticular<br />
veins and telangiectasia: 12 months results of a randomized trial<br />
AP3.7-10 R. Lonardi: Endo-perivenous laser procedures for teleangectasias treatment<br />
AP3.7-11 K. Miyake: Clacs guided by the veinviewer: new therapy for cosmetic leg vein<br />
treatment (4 years experience)<br />
AP3.7-12 B. Palmieri: Polymerized hyaluronic acid in lower legs teleangiectasia and varicose<br />
veins treatment<br />
Bosio Session of the French Society of Phlebology :<br />
14.00-16.00 1st Part: Cooperative studies of the French Society of Phlebology (BO3.7)<br />
Chairpersons: J.P. Gobin, J.F. Uhl<br />
BO3.7-1 O. Pichot , F.A. Allaert, A. Caggiati, S. Chastanet, A. Colignon, D. Creton, J. Garces,<br />
O. Hartung, P. Pittaluga, B. Rea, J.F Uhl (cooperative study of the French Society<br />
of Phlebology): Prospective multicenter study for the evaluation of the ASVAL<br />
method to treat varicose veins : objectives and preliminary protocol<br />
BO3.7-2 G Gachet: The SOV concept. A new approach for preserving saphenous vein trunk<br />
BO3.7-3 J.F Uhl ,B. Cales, G. Cohen-Solal, D. Creton, J.P. Gobin, J.C Scialom (cooperative<br />
study of the French Society of Phlebology) CELON: a new Radio Frequency<br />
technique for thermical ablation of the great saphenous vein:<br />
multicenter prospective study about 65 cases: preliminary results<br />
BO3.7-4 J.P Gobin, J.P Benigni, F.A Allaert (cooperative study of the French Society of<br />
Phlebology): Prospective case-control study on the effect of sclerotherapy<br />
on the healing speed of venous ulcers and their recurrence within 1 and 2 years<br />
BO3.7-5 M. Chahim, J.F Uhl, F.A Allaert (cooperative study of the French Society of Phlebology):<br />
Correlation between CVD and the static foot disorders
S C I E N T I F I C P R O G R A M M E<br />
BO3.7-6 F.A Allaert: Methods for the evaluation of utility, usefulness and efficiency of<br />
venoactive drugs<br />
BO3.7-7 J.P. Benigni, J.P Gobin, F.A. Allaert (cooperative study of the French Society of<br />
Phlebology): Results of an observational prospective study of a new venoactive<br />
food supplementation AXOVEN®<br />
BO3.7-8 V. Crebassa: New ultrasound technology without Doppler for venous desease<br />
exploration: the B-Flow<br />
BO3.7-9 J.L. Gerard, B. Cales, E. Girou: Prevention of infection in outpatient clinic.<br />
Proposal for guidelines<br />
Genevoix Free Paper Session: Lymphedema/ Pelvic Veins (GE3.7)<br />
14.00-16.00 Chairperson: C. Campisi<br />
Moderator: J. Laredo<br />
GE3.7-1 N. Piller: When the vascular system is in failure: strategies to improve lymphatic<br />
transport<br />
GE3.7-2 A. Ladwig: Therapy of secondary lymphedema of the arm<br />
GE3.7-3 P. Mortimer: Venous valve failure a phenotype of genotyped lymphoedema<br />
GE3.7-4 L. Flota Cervera: Mycrocirculatory physiological concepts of lymphedema<br />
GE3.7-5 C. Campisi: LVA microsurgical indications<br />
GE3.7-6 J. Krapp: There is now indication for surgery in lymphedema?<br />
GE3.7-7 V. Melita: Automatic mesotherapy guns, in lower leg mesenchymal treatment:<br />
indications, protocols and follow up<br />
GE3.7-8 S. Langendoen: Lipedema: from clinical presentation to therapy<br />
GE3.7-9 F. Bastos: Anatomie des veins ovariennes humaines<br />
GE3.7-10 A. Kurklinsky: A case of combined nutcracker and May-Thurner Syndromes in an<br />
adult with resolution of hemodynamic findings<br />
GE3.7-11 S. Zubico Ezpelata: Pelvic leaks<br />
16.00-16.30 Coffee break in Exhibition hall<br />
WEDNESDAY, SEPTEMBER 2 nd<br />
16.30-18.30<br />
Prince Pierre Free Paper Session: Endovenous Procedures 6: Combined Treatment (PP3.8)<br />
Chairperson: T. Proebstle<br />
Moderator: C. Jeanneret<br />
PP3.8-1 R. Simkin: Combined surgery with endovenous laser, Müller technique<br />
and videoscopy<br />
PP3.8-2 M. Parikov: Role on tributaries GSV to formation long stump after endovenous<br />
laser treatment<br />
PP3.8-3 C. Hayes: The effect of endovenous laser ablation on the restless legs syndrome<br />
PP3.8-4 M. Dhobb: Anatomical limits of endovenous laser obliteration in the great<br />
saphenous vein: combined treatment for optimal results<br />
PP3.8-5 S. Ray: One-stop treatment of varicose veins by radiofrequency ablation and miniphlebectomies<br />
PP3.8-6 F. Carrer: The first five minutes of the great saphenous vein after 808 nm diode<br />
laser ablation. Further details of the histological study<br />
PP3.8-7 R. Velletaz: 1008 Endovenous Laser Treatment (EVLT) personal experience<br />
PP3.8-8 R. Simkin: Klipplel Trenaunay syndrome: treatment with endovenous laser<br />
preliminary results & long term results with the regional segmental skeletization<br />
technique<br />
PP3.8-10 R. Shepherd: Is endothermal ablation the answer to patient satisfaction?<br />
PP3.8-11 J. Ulloa: Use of CO2 laser in lipodermatosclerosis<br />
PP3.8-12 L. Dzieciuchowicz: The value of ultrasound guided femoral nerve block in patients<br />
undergoing endoluminal laser ablation of great saphenous vein<br />
25
26<br />
WEDNESDAY, SEPTEMBER 2 nd<br />
S C I E N T I F I C P R O G R A M M E<br />
Camille Blanc Free Paper Session: Venous Surgery 1 (CB3.8)<br />
16.30-18.30 Chairperson: A. Van Rij<br />
Moderator: P. Pittaluga<br />
CB3.8-1 F. Passariello: Management of spontaneous SFJ/SPJ acute thrombosis -<br />
a vasculab survey<br />
CB3.8-2 C. Pereira-Alves: Minimally invasive selective surgery of primary varicose veins of<br />
lower limbs<br />
CB3.8-3 G. Tommasi: Hemodynamic and selective surgery of safeno femoral junction in<br />
patients with portal hypertension<br />
CB3.8-4 M. Vandendriesche: Surgery of the small saphenous vein, a personal series<br />
CB3.8-5 A. C. Shepherd: Recruitment to valve trial: the pros and cons of eligibility criteria<br />
CB3.8-6 C. Lim C: Secondary care treatment of patients with varicose veins in NHS<br />
England - an NHS website study<br />
CB3.8-7 J. Avram: Relapsed varicose disease - etiopathogeny, methods of treatment<br />
CB3.8-8 P. Casoni: Stump evolution after free crossectomy GSV saphenectomy:<br />
analysis in 500 cases<br />
CB3.8-9 G. Bruning: Recurrent varicosis and quality of life after varicose surgery:<br />
6 years follow up<br />
CB3.8-10 N. Frings: Reduction of neovascularisation at the saphenofemoral junction by<br />
extensive crossectomy<br />
CB3.8-11 P. Pittaluga: Surgical treatment for varicose recurrence: is inguinal redo surgery<br />
justified?<br />
Apollinaire Bauerfeind Symposium (AP3.8)<br />
16.30-18.30 The venous ulcer - patient between compression and intervention<br />
Chairperson: M. Jünger<br />
AP3.8-1 M. Perrin: Venous Interventions in ulcer patients - what is evidence based?<br />
AP3.8-2 T. Wentel: Evidence based compression in venous ulcer patient: bandage or<br />
stocking?<br />
AP3.8-3 C. Glynn: Pain management of venous ulcer<br />
AP3.8-4 M. Zutt: Modern wound management and treatment of wound infections<br />
Requirement and scope of modern wound dress systems in combination<br />
with efficient compression therapy<br />
AP3.8-5 M. Jünger: Natural care and protection of skin: advantage of algae ointment<br />
for the phlebological patient<br />
AP3.8-6 G. Ebert: Fascinating world of Nanoalgae<br />
Bosio Session of the French Society of Phlebology: (BO3.8)<br />
16.30-18.30 2 nd Part: Treatment of chronic venous disorders: French and Russian convergences<br />
Chairpersons: A.Shimanko, J.P. Benigni<br />
Moderators: M. Schadeck, R. Dremov<br />
BO3.8-1 M. Schadeck: Duplex guided sclerotherapy: respective indications of liquid and<br />
foam<br />
BO3.8-2 S. Krylov: Is varicose vein pattern implicated with efficacy of foam sclerotherapy<br />
of saphenous trunk?<br />
BO3.8-3 J.M. Diamand: Foam sclerotherapy of GSV with polidocanol 3% vs 1%: a<br />
randomized controlled study. 36 months follow up<br />
BO3.8-4 A. Shimanko: Minimally invasive technologies in the treatment of the varicose<br />
disease<br />
BO3.8-5 F. Vin: Endovenous Laser treatment of Short Saphenous Vein (SSV)<br />
BO3.8-6 E. Burleva: The incompetent perforating veins: some aspects of hemodynamic and<br />
surgical treatment
WEDNESDAY, SEPTEMBER 2 nd<br />
S C I E N T I F I C P R O G R A M M E<br />
BO3.8-7 R. Dremov: Combined therapy in patients with varicose veins and lower<br />
extremities lymphedema<br />
BO3.8-8 J.P. Benigni, A.Cornu-Thénard, J.F. Uhl: Efficiency of Medical Compression<br />
Stockings (MCS) and Venous Disorders: is pressure the only useful criteria ?<br />
Genevoix Free Paper Session: Venous Ulcer Treatment, Grafts (GE3.8)<br />
16.30-18.30 Chairperson: J. Benigni<br />
Moderator: P.L. Antignani<br />
GE3.8-1 D. De Anna: The biotechnologies in the treatment of neuro-vascular ulcers of the<br />
lower limbs. Cultivated autograft of skin: fibroblasts and/or cheratinocytes<br />
GE3.8-2 E. De Boer: Autologous cultured skin, Tiscover® for ambulant treatment of hardto-heal<br />
leg ulcers: a revolutionary approach<br />
GE3.8-3 G. Mosti: Allograft in the treatment of nonhealing skin ulcers<br />
GE3.8-4 S. Mancini: Leg ulcers treatment with homologous graft<br />
GE3.8-5 S. Mancini: Platelet gel in the treatment of distal leg ulcer<br />
GE3.8-6 M.Stücker: The soft-focused shock wave therapy activates the healing of long<br />
lasting and therapy resistant venous ulcers - results of a pilot study<br />
GE3.8-7 M.Simka: Air-plethysmographic prognostic factors of delayed healing of venous<br />
leg ulcers<br />
GE3.8-8 R. Lonardi: Multidisciplinary chronic leg ulcers service in Modena: data analysis<br />
GE3.8-9 A. Körber: Differentiated analysis of the aetiology of 30,466 patients with chronic<br />
leg ulcers in Germany<br />
GE3.8-11 M. Simka: Seasonal variations in the onset and healing rates of venous leg ulcers<br />
27
28<br />
S C I E N T I F I C P R O G R A M M E<br />
Thursday, September 3 rd<br />
07.30-08.45<br />
Apollinaire Talk to the experts (AP4.1)<br />
K. Parsi: Interaction of Detergent Sclerosants with the coagulation system:<br />
an update<br />
M. Schadeck: discussant moderator<br />
Bosio Talk to the experts (BO4.1)<br />
A. Comerota: DVT - how to treat in daily practice?<br />
M. Kurtoglu: discussant moderator<br />
Genevoix Talk to the experts (GE4.1)<br />
L. Kabnick: Radiofrequency and Laser Venous Ablation:<br />
Results and Complications<br />
O. Pichot: discussant moderator<br />
08.45-09.00 Coffee break in Exhibition hall<br />
09.00-11.00<br />
Prince Pierre Varicose Veins (PP4.2)<br />
Chaiperson: M. Perrin<br />
Moderator: J. Barrett<br />
PP4.2-1 E. Rabe: Epidemiology of varicose veins<br />
PP4.2-2 A. Caggiati: The role of saphenous tributaries in the development of primitive<br />
varicose veins<br />
PP4.2-3 P. Pittaluga: Tributary treatment in saphenous insufficiency - outcome after 4<br />
years<br />
PP4.2-4 A. Van Rij: Prevention of recurrent varicose veins after surgery<br />
PP4.2-5 F. Pannier: Outcome after endovenous laser ablation<br />
PP4.2-6 L. Kabnick: Laser Update: New Wavelength or New Laser Fibers?<br />
PP4.2-7 B. Disselhoff: Do we need SFJ ligation in endovenous procedures?<br />
PP4.2-8 N. Morrison: Foam sclerotherapy - the challenge of neurological symptoms<br />
PP4.2-9 J.L. Gillet: Physiopathology of visual disturbances occurring after<br />
foam sclerotherapy<br />
PP4.2-10 A. Frullini: New perspectives in collagen shrinking in venous insufficiency<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
11.00-11.30 Coffee break in Exhibition hall<br />
11.30-12.00<br />
Prince Pierre Guest lecture (PP4.3)<br />
Chaiperson: C. Jantet<br />
P. Neglen: Chronic Venous Insufficiency - Think Obstruction!<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
12.00-13.00<br />
Prince Pierre <strong>UIP</strong> Consensus Venous Oedema and Skin Changes (PP4.4)<br />
Chairperson: J. Strejcek<br />
Moderator: I. Staelens<br />
PP4.4-1 J.J. Guex: Development of a questionnaire to evaluate the burden of venous<br />
disease on daily life<br />
PP4.4-2 A. Davies: Recommendations for evaluation of outcomes after treatment<br />
of C0s-C4 patients
S C I E N T I F I C P R O G R A M M E<br />
PP4.4-3 A. Scuderi: <strong>UIP</strong> consensus in diagnosis and treatment of venous œdema<br />
PP4.4-4 A. Cornu-Thénard: <strong>UIP</strong> consensus in diagnosis and treatment of CVI related skin<br />
changes<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
13.00-14.00<br />
Bosio Servier Vein Consult Project (BO4.5)<br />
Chairpersons: E. Rabe, J.J. Guex<br />
BO4.5-1 E. Rabe: Chronic venous disease: magnitude of the problem and unsolved<br />
questions<br />
BO4.5-2 J.J. Guex: An international Vein Consult Program: for what?<br />
BO4.5-3 A. Puskas, V. Bogachev, J.J. Guex: Description of the Vein Consult Program:<br />
assessment by GPs, specialists and patients<br />
BO4.5-5 S. Milic: Which data can we expect from the Vein Consult Program?<br />
13.00-15.00<br />
Auric Session of the German Society of Phlebology (AU4.5)<br />
General Assembly<br />
14.00-15.00<br />
Presentation of posters by authors DIA 47 to 61<br />
Chairpersons: M. Schadeck, H. Gerlach<br />
Discussants: M. Cazaubon, M. Patel<br />
THURSDAY, SEPTEMBER 3 rd<br />
14.00-16.00<br />
Prince Pierre Free Paper Session: Sclerotherapy 5: Saphenous Veins (PP4.6)<br />
Chairperson: J. Kuiper<br />
Moderator: P. Raymond-Martinbeau<br />
PP4.6-1 M. Sica: Ultrasound guided sclerotherapy with micro-foam: a free, practical and<br />
illustrated guide with DVD<br />
PP4.6-2 S.Vayuvegula: Long-term results of a staged sequential sclerotherapy protocol for<br />
the treatment of junctional reflux<br />
PP4.6-3 S. Reich-Schupke: A double-balloon catheter for foam-sclerotherapy of the great<br />
saphenous vein - critical review on preliminary results<br />
PP4.6-4 C. Hamel-Desnos: Foam versus liquid polidocanol in sclerotherapy of the great<br />
saphenous vein: a multicentre randomized controlled trial with a two-year<br />
follow-up<br />
PP4.6-5 C. Hamel-Desnos: Comparison of 1% and 3% polidocanol foam in sclerotherapy of<br />
the great saphenous vein: a randomized, double-blind trial with 2 year-follow-up.<br />
‘‘The 3/1 study’’ for the French Society of Phlebology<br />
PP4.6-6 M. Schadeck: Liquid or foam: which one is the best?<br />
PP4.6-7 F. Ferrara: Failures of sclerotherapy of the great saphenous vein, clinical<br />
and subclinical recurrencies<br />
PP4.6-8 A. Cornu-Thénard, M. Schadeck, J.F. Uhl: Sclerotherapy modalities of the GSV<br />
and inflammatory complications<br />
PP4.6-9 A. Cavezzi: Phlebectomy of varicose tributaries combined with transcatheter foam<br />
sclerotherapy of the saphenous vein: a randomized controlled study<br />
PP4.6-10 N. Shadid: Cost minimization study comparing surgery vs duplex guided foam<br />
sclerotherapy of varicose veins: a randomized controlled study<br />
29
30<br />
THURSDAY, SEPTEMBER 3 rd<br />
S C I E N T I F I C P R O G R A M M E<br />
PP4.6-11 C. Hamel-Desnos: Foam sclerotherapy of saphenous veins and biological<br />
consequences on circulating blood. Controlled randomized study with or without<br />
compression stockings<br />
PP4.6-12 P. Van Dale: Should we still remove incompetent short saphenous vein?<br />
Camille Blanc Joint Symposium on Phlebolymphedema<br />
14.00-16.00 International Union of Phlebology & European Society of Lymphology (CB4.6)<br />
Chairpersons: H. Partsch, S. Michelini<br />
CB4.6-1 S. Michelini: Physiopathology of phlebolymphedema<br />
CB4.6-2 B.B. Lee: Diagnostic and therapeutical implications in truncular and extratruncular<br />
lympho-venous malformations<br />
CB4.6-3 P. Bourgeois: Nuclear medicine in Phlebolymphology<br />
CB4.6-4 R.J. Damstra: The treatment of large arm<br />
CB4.6-5 C. Lohrmann: MR- Lymphangiography<br />
CB4.6-6 H.G.J. Voesten: The surgical indications in Lymphedema<br />
CB4.6-7 C. Campisi: LVA microsurgical indications<br />
CB4.6-8 H. Partsch: Evidence based elastocompressure in phlebolymphology<br />
CB4.6-9 A. Pissas: Prevention of lymphedema: give good advices to the patients, but<br />
essentially to the surgeons and the radiotherapist!<br />
CB4.6-10 A. Leduc: European consensus on physical treatment of phlebolymphedema<br />
Discussion<br />
Apollinaire Free Paper Session: Endovenous Procedures 7 - Complications (AP4.6)<br />
14.00-16.00 Chairperson: JL. Gillet<br />
Moderator: T. Noppeney<br />
AP4.6-1 P. Sridhar: Postoperative pain and return to work following endovenous<br />
laser ablation of varicose veins<br />
AP4.6-2 R. Vellettaz: Complications in EVLT<br />
AP4.6-3 L. Kabnick: Are DVT rates higher for radiofrequency ablation of small saphenous<br />
veins?<br />
AP4.6-4 T. King: How safe and effective is high energy endovenous laser ablation?<br />
AP4.6-5 T. King: Can saphenous and sural nerve paresthesia be prevented during ELT?<br />
AP4.6-6 H. Agis: Minimization of thermally induced thrombosis of the sapheno-femoral<br />
junction during endothermal ablation of the great saphenous vein; safe position<br />
for catheter tip placement<br />
AP4.6-7 L. Kabnick: Endothermal heat induced thrombosis: classification, natural history<br />
and treatment guidelines<br />
AP4.6-8 S. Kaspar: Comparison between traditional and endovenous laser varicose veins<br />
procedure in terms of quality of life<br />
AP4.6-9 R.R. Van Den Bos: Complications of endovenous laser ablation: review of the<br />
literature and special cases<br />
AP4.6-10 K. Böhler: Does laser induced endothelial damage of the great saphenous vein<br />
extend into the saphenofemoral junction?<br />
Bosio Session of the American Venous Forum (BO4.6)<br />
14.00-16.00 Chairperson: J. Lohr<br />
BO4.6-1 M. Vasquez: Venous Clinical Severity Scoring Update<br />
BO4.6-3 M. Lohr: Speaking the same language - venous ultrasound controversies<br />
BO4.6-4 M. Meissner: Pelvic Venous Congestion<br />
BO4.6-5 B. Eklöf: Renaissance for Early Thrombus Removal in Acute Iliofemoral DVT:<br />
Role of Mechanical and Surgical Thrombectomy<br />
BO4.6-6 J. Comerota: Role of Lytics<br />
BO4.6-7 S. Raju: Modern concepts in the pathophysiology of chronic venous disease<br />
BO4.6-8 M. Dalsing: Options for Venous Valve Repair / Replacement
S C I E N T I F I C P R O G R A M M E<br />
Genevoix Short Free Paper Session II (GE4.6)<br />
14.00-16.00 Chairperson: L. Schimmelpfenning<br />
Moderator: A. Gasparis<br />
GE4.6-1 E. Bernardini: Echo-sclerosis hemodynamic conservative (ESEC). A new method<br />
for venous insufficiency treatment<br />
GE4.6-2 K. Hartmann: Reversible neurological deficit after foam sclerotherapy<br />
GE4.6-3 U. Alonzo: Sclero-mousse in great saphenous vein insufficiency; long term results<br />
GE4.6-4 M. Valsamis: Soft sclerotherapy of the hand veins<br />
GE4.6-5 S. Belentsov: Ultrasound-guided foam sclerotherapy: which main conclusions to<br />
be drawn from the experience of 2440 procedures. Short-term results and threeyear<br />
follow up<br />
GE4.6-6 A. Hamahata: Outcomes of ultrasound-guided foam sclerotherapy for varicose<br />
veins of the lower extremities - single center experience<br />
GE4.6-7 J. Diez: Pathological anatomy of the venous wall after treatment with endoluminal<br />
laser. Immediate and thirty days after surgery observations<br />
GE4.6-8 M. Perrin: Michel Perrin for the transatlantic interdisciplinary group: the<br />
updated terminology of chronic venous disorders: the vein-term transatlantic<br />
interdisciplinary consensus document<br />
GE4.6-9 J. Benigni: Compression bandages influence of techniques of use on their clinical<br />
efficiency and tolerance<br />
GE4.6-10 J. Benigni: Friction index of medical compression stockings<br />
GE4.6-11 J. Delic: Link between etiological aspects of veins thrombosis and clinic image of<br />
the disease<br />
GE4.6-12 E. Bobrovsky: Ulcers healing and platelet growing factor<br />
GE4.6-13 M.Simka: Giant leg ulcers: are they actually venous ones?<br />
GE4.6-14 K.Kikuchi: Practical way to compare and document outcome on leg vein lesions<br />
treatment<br />
GE4.6-15 R. Garay: Antioxidant/anti-inflammatory effects of calcium dobesilate (doxiumR) in<br />
human varicose veins<br />
GE4.6-16 J. Delic: Home health care in angiology: practice and evidence based<br />
recommendations<br />
GE4.6-18 P. Molski: Manual lymphatic drainage improves the quality of life in patients with<br />
chronic venous disorders<br />
GE4.6-19 P. Bhaskaran: Electrolyte balance in pulsatile and non-pulsatile patients<br />
undergoing coronary artery bypass graft<br />
GE4.6-20 S. Sapelkin: Regionary venous renal hyperthension - diagnostic, treatment tactic<br />
GE4.6-21 V. Ciubotaru: Varices’ ambulatory non-stripping surgical therapy (VANST)<br />
GE4.6-22 Z. Böhm: Minisurgical concept in the treatment of varicose veins (preserve of the<br />
saphenous vein - miniphlebectomy)<br />
16.00-16.30 Coffee break in Exhibition hall<br />
THURSDAY, SEPTEMBER 3 rd<br />
16.30-18.30<br />
Prince Pierre Free Paper Session: Venous Diagnosis 2 (PP4.7)<br />
Chairperson: F. Vin<br />
Moderator: V. Wienert<br />
PP4.7-1 J. Leal Monedero: The Nutcracker Syndrome<br />
PP4.7-2 A. Kornberg: Diagnosis and treatment of venous pelvic. Syndrome congestion<br />
pelvic vulvar varicose vein<br />
PP4.7-3 A. Sanchez-Galan: Left renal vein compression syndrome: diagnosis with duplex<br />
ultrasound<br />
PP4.7-4 S. Katorkin: Varicose pelvic vein disease: diagnosis and therapy<br />
PP4.7-5 O. Hartung: Risk factors of technical failure during endovascular treatment of<br />
post-thrombotic femoro-iliac venous obstructive lesions<br />
31
32<br />
THURSDAY, SEPTEMBER 3 rd<br />
S C I E N T I F I C P R O G R A M M E<br />
PP4.7-6 M. Kazakmurzaev: Reflux of the proximal femoral vein valves can be corrected by<br />
an angioscopically directed vedensky spiral<br />
PP4.7-7 N. Morrison: Prevalence of reflux in the great saphenous vein as a function<br />
of diameter<br />
PP4.7-8 S. Ray: The prevalence of bilateral saphenous reflux and abnormal venous refilling<br />
times in patients with varicose veins<br />
PP4.7-9 T. Spina: Distribution of venous reflux in CVI of the lower limbs, by duplex<br />
investigation<br />
PP4.7-10 F. Vega.: A method for the diagnosis and record of venous insufficiency with<br />
pocket doppler´s use<br />
PP4.7-11 M. Markovic: The role of ultrasonography in surgical treatment of acute<br />
thrombophlebitis of great saphenous vein<br />
PP4.7-12 T. Spina: The value of doppler venous pressure index in the diagnosis of chronic<br />
venous insufficiency of the lower limbs<br />
Camille Blanc BSN Jobst Symposium<br />
16.30-18.30 Patient compliance in compression therapy - Does it really matter? (CB4. 7)<br />
Chairperson: E. Rabe<br />
CB4.7-1 E. Rabe: What does Compliance mean?<br />
CB4.7-2 F. Pannier: Further results of the Bonn Vein Study on compliance of CVI patients<br />
CB4.7-3 E. Rabe: Results of a prospective and retrospective research on compliance of<br />
CVI patients in Germany<br />
CB4.7-4 C. Moffat: Compliance issues of venous ulcer patients<br />
CB4.7-5 S. Vignes: Importance of compliance in management of arm lymphedema after<br />
breast cancer treatment<br />
CB4.7-6 JP. Benigni: Efficiency of low pressure Medical Compression Stockings (MCS) on<br />
venous symptoms: a micro-massage effect?<br />
Apollinaire Free Paper Session: Thromboembolic diseases 1 (AP4.7)<br />
16.30-18.30 Chairperson: J. Lohr<br />
Moderator: M. Kurtoglu<br />
AP4.7-1 M. Kurtoglu: Venous thromboembolism prophylaxis methods in the trauma and<br />
emergency surgery intensive care unit patients<br />
AP4.7-2 J. Scurr: Travellers’ thrombosis: airlines still not giving passengers the wright advice!<br />
AP4.7-3 C. Jeanneret-Gris: Deep venous thrombosis investigated with ultrasound<br />
contrast agent<br />
AP4.7-4 R. Bauersachs: Gender difference in clinical presentation of deep vein thrombosis<br />
AP4.7-5 S. Schulz: Deep venous thrombosis and varicosity<br />
AP4.7-6 T. Yamaki: Presence of lower limb deep vein thrombosis and prognosis in patients<br />
with symptomatic pulmonary embolism<br />
AP4.7-7 A. Tucker: Blood flow increase via a novel method of electrical nerve stimulation<br />
in the lower leg is suitable for DVT prevention<br />
AP4.7-8 A. Gasparis: Prospective determination of candidates for pharmacomechanical<br />
thrombolysis<br />
AP4.7-9 R. Bauersachs: Safety and efficacy of low-molecular-weight heparin (dalteparin)<br />
in pregnant women at increased risk of venous thromboembolism:<br />
a prospective stratified multicentre trial<br />
AP4.7-10 J. Avram: Superficial thrombophlebitis - complications and treatment<br />
AP4.7-11 Lefeng Qu: Diagnosis and treatment of deep venous thrombosis caused by<br />
pelvic tumor<br />
AP4.7-12 J. Ragg: Five Modalities for Mini-Thrombectomy of epifascial veins
S C I E N T I F I C P R O G R A M M E<br />
Bosio Session of the American College of Phlebology ( BO4. 7)<br />
16.30-18.30<br />
THURSDAY, SEPTEMBER 3 rd<br />
BO4.7-1 J. Mauriello, E.J. Sanchez, J. White, W. Schroedter, B. White: Preliminary results of<br />
low energy density laser ablation treatment of incompetent truncal veins<br />
BO4.7-2 J. A. Zygmunt Jr: Understanding Duplex Venous Ultrasound for Phlebology<br />
BO4.7-3 L. Kabnick: A new phlebectomy algorithm: first, second, third<br />
BO4.7-4 S. Zimmet: American Board of Phlebology: Certification Examination<br />
BO4.7-5 T. Morrison: Compression therapy after phlebologic interventions: How Much?<br />
How Long? How High? A United States Perspective<br />
BO4.7-6 P. Raymond-Martimbeau: Effectiveness of single injection of sodium tetradecyl<br />
sulfate on predicting outcomes following ultrasound foam sclerotherapy using<br />
ultrasound scoring system<br />
BO4.7-7 D. Neuhardt: Differences in saphenous vein reflux detection according to patient<br />
positioning<br />
BO4.7-8 N. Morrison: The complementary roles of surgery, endovenous thermal ablation,<br />
and foam sclerotherapy in the treatment of chronic venous insufficiency -<br />
the U.S. perspective<br />
BO4.7-9 J. Bergan: Venous Ulcers: How to treat them without surgery<br />
Genevoix Short Free Paper Session III (GE4.7)<br />
16.30-18.30 Chairpersons: N. Rosli<br />
Moderator: P. Neglen<br />
GE4.7-1 T. Yasugi: A case of combined therapy for the arteriovenous malformation in<br />
the tigh - surgery and interventional radiology<br />
GE4.7-2 N. Morrison: Endovenous thermal ablation of patient with klippel-trenaunay<br />
syndrome<br />
GE4.7-3 P. Chapman-Smith: Endovenous laser ablation with 1320nm of an arm venous<br />
malformation<br />
GE4.7-4 L. Chernukha: Complex treatment of venous and arterio-venous congenital<br />
vascular malformations of the lower limbs<br />
GE4.7-5 L. Kanina: Treatment of patients suffering from dysplasia of superficial vein upper<br />
and lower extremities<br />
GE4.7-7 E. Tsolaki: The C.E.A.P.-L classification for lymphedemas of the limbs<br />
Our experience<br />
GE4.7-8 D-A.A. Lamprou: Relationship between interface pressure and operative volume<br />
reduction in patients with lymphedema of the extremities<br />
GE4.7-9 E. Bobrovsky: Lymphangiogenesis in the rabbit ear using stem cells from<br />
peripherical blood under stimulation by G_CSF (filgrastim)<br />
GE4.7-10 R. Belmonte: Efficacy of sound waves in the upper limb lymphedema treatment<br />
GE4.7-11 M. Ruzicka: Treatment of cystic retroperitoneal lymphangioma<br />
GE4.7-12 A. Brigic: Targets and a robust delivery model are required to stop hospitalized<br />
patients being put at risk from venousthromboembolism<br />
GE4.7-13 M. Schul: Superficial thrombophlebitis: a case report with a life threatening<br />
complication<br />
GE4.7-14 J. Delic: Polycithemia Rubra Vera (PRV) – venous thrombosis risk factors<br />
GE4.7-15 E. Burleva: Deep venous thrombosis: an overview of hospital treatment<br />
GE4.7-16 G. Arpaia: Risk of DVT in wheelchair-bound or bedridden patients with multiple<br />
sclerosis: a prospective study<br />
GE4.7-18 L. Zhang: Four-dimensional computed tomography perfusion imaging for<br />
DVT/PATE application<br />
33
34<br />
S C I E N T I F I C P R O G R A M M E<br />
Friday, September 4 th<br />
07.30-08.45<br />
Apollinaire Talk to the experts (AP5.1)<br />
A. Cavezzi: Foam Sclerotherapy and phlebectomy - what are the best strategies?<br />
T. Yamaki: discussant moderator<br />
Bosio Talk to the experts (BO5.1)<br />
P. Neglen, S. Raju: Ilio-femoral obstruction - how to treat the disease?<br />
K. Burnand: discussant moderator<br />
Genevoix Talk to the experts (GE5.1)<br />
E. Rabe: US Guided foam sclerotherapy: references and practical applications<br />
F. Vin: discussant moderator<br />
08.45-09.00 Coffee break in Exhibition hall<br />
09.00-11.00<br />
Prince Pierre Deep Venous Insufficiency (PP5.2)<br />
Chaiperson: O. Maleti<br />
Moderator: N. Labropoulos<br />
PP5.2-1 H. Gerlach: Three year follow up of patients with DVT monitored in the TULIPA<br />
registry<br />
PP5.2-2 A.Van Rij: The time sequence of the development of axial deep reflux following<br />
lower limb DVT - a prospective study over 5 years<br />
PP5.2-3 S. Raju: Iliac vein stenting - indications and long term results<br />
PP5.2-4 O. Hartung: Long-term results of stenting for femoro-iliac veins obstructive lesions<br />
PP5.2-5 H. Partsch: Prevention of postthrombotic syndrome with compression treatment -<br />
evidence from comparative studies<br />
PP5.2-6 N. Labropoulos: Impact of iliofemoral thrombosis on the development of<br />
postthrombotic syndrome<br />
PP5.2-7 O. Maleti: Neovalve in postthrombotic syndrome - long term results<br />
PP5.2-8 M. Dalsing: The future of artificial venous valves<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
11.00-11.30 Coffee break in Exhibition hall<br />
11.30-12.00<br />
Prince Pierre Guest lecture (PP5.3)<br />
Chaiperson: C. Allegra<br />
B.B. Lee: Embryology of the venous network<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)<br />
12.00-13.00<br />
Prince Pierre <strong>UIP</strong> Consensus Venous malformation & Lymphoedema (PP5.4)<br />
Chairpersons: B.B. Lee, N. Piller<br />
PP5.4-1 B.B. Lee: Consensus on Venous Malformation<br />
PP5.4-2 B.B. Lee: Consensus on Primary lymphœdema, lymphatic malformation<br />
PP5.4-3 N. Piller: Secondary phlebo-lymphoedema: definition, diagnosis and treatment<br />
Camille Blanc Video of Salle Prince Pierre session (In case of overcrowding of room Prince Pierre)
FRIDAY, SEPTEMBER 4 th<br />
S C I E N T I F I C P R O G R A M M E<br />
14.00-16.00<br />
Prince Pierre Free Paper Session: Endovenous Procedures 8 / Treatment<br />
Sclerotherapy 6 - Safety (PP5.6)<br />
Chairperson: K. Myers<br />
Moderator: J. Mauriello<br />
PP5.6-1 L. Corcos: Endovenous 808 nm diode laser ablation of varicose collaterals.<br />
Clinical and instrumental results after six years<br />
PP5.6-2 V. Barucchello: Endovenous 808 nm diode laser ablation of incompetent<br />
perforators. Clinical and instrumental results after six years<br />
PP5.6-3 L. Corcos: Laser-assisted surgery of hemorrhoids by 808 nm diode laser<br />
PP5.6-4 D. Pontello: Duplex and histological changes of the great saphenous vein in twelve<br />
months after 808 nm diode laser irradiation. Further details<br />
PP5.6-5 B. Elezi: Endovenous 808 nm diode laser ablation of incompetent saphenous<br />
veins. Clinical and duplex results after six years<br />
PP5.6-6 J. Rush: Endovenous microfoam ablation in patients with migraine headache<br />
with and without Right-to-Left (R-L) cardiac shunt<br />
PP5.6-7 J. Rush: Lack of concordance between presence of Right-to-Left shunt and<br />
detection of middle cerebral artery emboli during endovenous microfoam<br />
ablation<br />
PP5.6-8 N. Morrison: Testing of maneuvers for prevention of foam migration during<br />
ultrasound-guided foam sclerotherapy<br />
PP5.6-9 D. Neuhardt: Correlation of cerebral emboli, symptoms, and volume injected<br />
during ultrasound guided foam sclerotherapy<br />
PP5.6-10 N. Morrison: Safety of ultrasound-guided foam sclerotherapy with physiological<br />
CO2-O2 gas<br />
PP5.6-11 D. Neuhardt: Cerebral emboli comparison detected by transcranial doppler during<br />
ultrasound- guided sclerotherapy using CO2/02-based foam or air-based foam<br />
PP5.6-12 M.V .Rubia: Safety and efficacy endovenous chemical ablation with polidocanol<br />
microfoam in elderly patients with chronic venous insufficiency<br />
Camille Blanc Sigvaris Symposium: Medical Compression Stockings (MCS) for venous disorders<br />
and diseases - original studies presented by the authors (CB5.6)<br />
Moderators: E. Rabe, H. Partsch, M. Perrin<br />
1 st Part: MCS for venous disorders<br />
Chaipersons : E.Rabe, M.Perrin<br />
CB5.6-1 E. Rabe: Use of MCS in the general population - Data from the Bonn Vein Study<br />
CB5.6-2 P. Kern: MCS after interventions on varicose veins<br />
CB5.6-3 F. Amsler: Meta-analysis of MCS for patients with venous disorders<br />
CB5.6-4 W. Blättler: MCS for occasional leg symptoms<br />
2 nd Part: MCS for venous ulcers and other severe venous diseases<br />
Chairpersons: J.J. Guex, H. Partsch<br />
CB5.6-5 E.O. Brizzio: Moderate strength MCS for the treatment of recalcitrant venous<br />
ulcers are not inferior to mutlilayer short-stretch bandages<br />
CB5.6-6 F. Mariani: RCT comparing a double stocking system (Ulcer X) with bandages<br />
CB5.6-7 F. Amsler: Meta-analysis of studies comparing MCS with bandages<br />
CB5.6-8 W. Blättler: Analysis of risk factors relevant to choose compression therapy for<br />
venous ulcers<br />
35
36<br />
FRIDAY, SEPTEMBER 4 th<br />
S C I E N T I F I C P R O G R A M M E<br />
CB5.6-13 S. Wagner: Round knitted MCS are not inferior to Flatt-knitted MCS for<br />
the treatment of stable lymphedema<br />
CB5.6-9 J.J. Guex: Experiences by doctors and patients of MCS 20-36mmHg<br />
CB5.6-10 D. Rastel: How to improve compliance of compression therapy (20-36 mmhg)?<br />
- biomechanics of MCS<br />
- survey on MCS compliance<br />
CB5.6-11 P. Humbert: Interactions of skin and MCS during donning process<br />
CB5.6-12 E. Le Floch: Survey on MCS compliance<br />
Apollinaire Free Paper Session: Varicose Veins-Miscelleanous (AP5.6)<br />
14.00-16.00 Chairperson: C. Pereira Alves<br />
Moderator: A.C. Benhamou<br />
AP5.6-2 Y. Herouy: The role of tight junctions in venous disease<br />
AP5.6-3 I. Bihari: Laser-Doppler Examination of Corona Phlebectatica Paraplantaris<br />
AP5.6-4 F. Allaert: Socioeconomic consequences of the phlebotonic drug<br />
de-reimbursement<br />
AP5.6-5 Y. Novikova: Pharmacogenomics: new reality of modern phlebology<br />
AP5.6-6 P. Carpentier: Evaluation of balneotherapy associated with patient education in<br />
patients with advanced chronic venous insufficiency: a randomized controlled<br />
trial in the spa Resort of la Léchère<br />
AP5.6-7 J.M. Chardenneau: Study on the effectiveness of medical treatment based on IRFA<br />
on legs cellulitis<br />
AP5.6-8 C. Simkin: Transdermal cryolaser and cryo sclerotherapy in the treatment of<br />
telangiectasies and reticular veins<br />
AP5.6-9 J. Lopez D´Ambola: Transdermal laser theraphy for the superficial venous<br />
insufficiency<br />
AP5.6-11 E. Rabe: Calcium dobesilate in patients suffering from chronic venous<br />
insufficiency. A double-blind, placebo-controlled, clinical trial<br />
Bosio Session of the European Venous Forum (BO5.6)<br />
14.00-16.00 Workshop on updating International guidelines on the prevention<br />
of venous thromboembolism<br />
Genevoix Free paper session: Venous Surgery 2 (GE5.6)<br />
14.00-16.00 Chairperson: O. Hartung<br />
Moderator: H. Fronek<br />
GE5.6-1 S. Camilli: The external stretching valvuloplasty: a new technique for venous valve<br />
repair<br />
GE5.6-2 S. Chastanet: Surgical treatment of varices with tumescent local anesthesia<br />
heavily diluted in bicarbonate: “the gentle surgery”<br />
GE5.6-3 P. Pittaluga: Value of the preservation of the saphenous vein for the surgical<br />
treatment of varices in young nullipara patients<br />
GE5.6-4 S. Chastanet: The effects of isolated phlebectomy on reflux and diameter of the<br />
great saphenous vein : a prospective study<br />
GE5.6-5 M. Lefebvre-Vilardebo: Saphenectomy without crossectomy, an easy and safe<br />
alternative solution to endovenous techniques<br />
GE5.6-6 P. Casoni: Is still crossectomy the first obliged step in varicose vein surgery?<br />
6 yrs follow up in a randomized study in 124 legs without inguinal dissection<br />
GE5.6-7 S. Gianesini: High ligation in chronic venous disease of the lower limbs: an<br />
unavoidable surgical approach?<br />
GE5.6-8 A. Scuderi: A strategy of varicose syndrome management based in haemodynamic<br />
concepts
S C I E N T I F I C P R O G R A M M E<br />
GE5.6-9 M. Lefebvre-Vilardebo: Varicose great saphenous vein: no need for treating 50%<br />
junctions. From a series of 790 legs<br />
GE5.6-10 G. Genovese: Role of the stick of sapheno-femoral im post LEV recurrence<br />
or stripping<br />
16.00-16.30 Coffee break in Exhibition hall<br />
FRIDAY, SEPTEMBER 4 th<br />
16.30-18.30<br />
Prince Pierre Free Paper Session: Venous Ulcer Treatment II (PP5.7)<br />
Chairperson: G. Mosti<br />
Moderator: O. Nelzen<br />
PP5.7-1 D. Milic: Multi-layer bandaging system with Tubulcus® in the treatment of venous<br />
leg ulcers<br />
PP5.7-2 G. Mosti: Elastic stockings and ulcer treatment: what about pressure and<br />
stiffness?<br />
PP5.7-3 P. Lloret: Treatment of 180 venous ulcers with microfoam sclerotherapy<br />
PP5.7-4 L. Hnatek: Radiofrequency-induced thermotherapy (RFITT) and ultrasound guided<br />
foam sclerotherapy - a comparison study for the treatment of chronic venous<br />
ulcers<br />
PP5.7-5 Z.Maksimovic: The significance of CEAP classification for choice of surgical<br />
method intreatment of venous ulcers<br />
PP5.7-6 B. Palmieri: Autologous stem cells injection in diabetic foot ulcer: an experimental<br />
and clinical study<br />
PP5.7-7 G. Daeschlein: MRSA- and infection-management of chronic wounds in<br />
dermatology<br />
PP5.7-8 A. Körber: Clinical investigation on Panton-Valentin Leukocidin (PVL)-positive<br />
staphylococcus aureus isolates in patients with chronic wounds<br />
PP5.7-9 A. Körber: Gram negative bacteria on the advance: results of a comparative<br />
clinical investigation in chronic leg ulcers about 5 years<br />
PP5.7-10 J. Dissemond: First results of a comparative analysis of 50 patients with chronic<br />
leg ulcers with a new technique (Essen Rotary) for bacterial smears<br />
PP5.7-11 S. Reich-Schupke : Practicable patch test program for patients with leg ulcers with<br />
special reference to products of modern wound care - results of a prospective<br />
study in correlation with literature<br />
PP5.7-12 B. Palmieri: Skin cancer following a long standing lower leg ulcer<br />
Apollinaire Short Free Paper session IV (AP5.7)<br />
Chairperson: M. Marshall<br />
Moderator: D. Neuhardt<br />
AP5.7-1 K. Wasilewski: Incompetent perforator vein ablation by endovenous laser<br />
treatment with 1470 nm laser - first report in the Middle East<br />
AP5.7-4 V.M. Canata: Endolaser venous system in Paraguay<br />
AP5.7-5 V. Patel: The management of combined greater and small saphenous vein reflux<br />
using endovenous laser ablation<br />
AP5.7-6 V. Brown: Single puncture technique for laser ablation and foam sclerotherapy to<br />
the great saphenous vein<br />
AP5.7-7 V. Brown: Patient-reported outcomes following simultaneous endovascular laser<br />
ablation of the small and great saphenous veins<br />
AP5.7-8 V. Patel: Endovenous laser ablation of the greater saphenous vein: early<br />
experience using a low energy radial fibre (ELVES)<br />
AP5.7-9 H. Sugawara: Transient thrombocytosis after endovenous laser treatment for<br />
primary lower extremity varicose vein<br />
37
38<br />
FRIDAY, SEPTEMBER 4 th<br />
S C I E N T I F I C P R O G R A M M E<br />
AP5.7-10 M. Kazakmurzaev: Prophylaxis of minor complications after endovenous laser<br />
treatment of primary varicose veins<br />
AP5.7-11 G. Botta: Recurrent varicose veins after endovenous laser treatment<br />
AP5.7-12 V. Ivan: The great saphenous vein crosse versus the saphenofemoral junction<br />
AP5.7-13 C. Lebard: Calculation of energy in segmental ablation of greater saphenous vein<br />
by radiofrequency<br />
AP5.7-14 M. Hirokawa: 1470nm endovenous laser treatment of the great saphenous vein:<br />
more than 5-month follow-up<br />
AP5.7-15 C. Hayes: Successful treatment of unilateral restless legs syndrome and<br />
superficial venous insufficiency with endovenous laser ablation and<br />
ultrasound-guided chemoablation<br />
AP5.7-16 A. Sanchez-Galan: Is the thrombosis of the Internal Saphenous Vein (ISV)<br />
post- endovenous laser treatment (EVLT) a predictive factor for the technique<br />
failure?<br />
AP5.7-17 J. Titon: Laser treatment of the telangiectasias of the feet, (360 patients treated<br />
during 4 years)<br />
AP5.7-18 V. Canata: Laser treatment of venous leg ulcer in Paraguay<br />
AP5.7-19 J. Hovorka: Report of improvement in hemodynamic dysfunction and disability<br />
secondary to CVD with Multiple Tributary Vein Ablation (MTVA) in 2 patients:<br />
correction of chronic obstruction (APG outflow fraction with superficial occlusion)<br />
AP5.7-20 S. IIda: Stripping under tumescent local anesthesia using ultrasound scanning<br />
during operation<br />
AP5.7-21 G. Makhatilov: Does preventive external correction of the GSV ostial valve change<br />
the course of varicose disease at healthy SFJ PTS?<br />
AP5.7-22 T. De Bo: The use of a new endovenous laser device: results of the 1500 nm laser<br />
Bosio Session of the Italian College of Phlebology<br />
16.30-18.30 Endovascular treatment of Varicose Veins (BO5.7)<br />
Chairpersons: C. Allegra, E. Rabe<br />
BO 5.7-2 E. Rabe: Endovenous procedures - the German experience<br />
BO5.7-3 V. Gasbarro: Radiofrequency indication and usefulness<br />
BO5.7-4 L. Tessari: Scleromousse as first choice<br />
BO5.7-5 M. Sica: Scleromousse: a technique in progress?<br />
BO5.7-6 P.L. Antignani: Thromboembolic complications: is it a problem?<br />
Genevoix Thromboembolic disease II (GE5.7)<br />
16.30-18.30 Chairperson: R. Simkin<br />
Modertor: M. De Maeseneer<br />
GE5.7-1 H. Kiesewetter: Thrombosis prophylaxis in endovenous interventions<br />
GE5.7-3 D. Jadranin: Venous thrombectomy vs. conventional anticoagulant treatment of<br />
iliofemoral venous thrombosis-early results and 6 months follow up<br />
GE5.7-4 F. Vin: Etiological diagnosis of 70 patients with deep vein thrombosis of lower<br />
limbs<br />
GE5.7-5 R.Kreidy: Contribution of factor V R 506 Q - leiden, prothrombin G 20210 A and<br />
MTHFR C 677 T mutation to the genetic susceptibility of deep vein thrombosis<br />
of lower extremities. Is screening for factor V H 1299 R and MTHFR A 1298 C<br />
justified?<br />
GE5.7-6 Y. Novikova: Determination of the haemostasis system’s genes: from standard to<br />
personalized medicine<br />
GE5.7-7 S. Michelini: Hyperhomocysteinemia and venous thrombosis: our experience
S C I E N T I F I C P R O G R A M M E<br />
GE5.7-8 H. Gerlach: Adherence to guidelines on current practice in diagnostic work-up of<br />
patients with suspicion of DVT<br />
GE5.7-9 J. Duque Botero: Prevalence of sticky platelets in a Colombian family, clinical<br />
implications, possible hereditable pattern and study of platelet receptors.<br />
Preliminary results<br />
GE5.7-10 F. Casals Sole: A normal D-dimer value, measured by a high sensitivity assay,<br />
rule out a suspected venous thromboembolism episode independently of pretest<br />
clinical probability<br />
GE5.7-11 W. Koeyers: Phlebography of the lower limb: revival of a dying art<br />
18.30<br />
Prince Pierre Closing remarks<br />
FRIDAY, SEPTEMBER 4 th<br />
39
40<br />
LIST OF ACCEPTED POSTERS<br />
Posters presented on Monday, August 31 st from 14.00 to 15.00 (Diaghilev area)<br />
DIA1 HISTORY AND CURRENT STATUS OF THE KOREAN SOCIETY OF PHLEBOLOGY - D. Kim<br />
DIA2 EFFECTIVENESS OF WEIGHT LOSS ON THE EVOLUTION OF CHRONIC VENOUS INSUFFICIENCY (CVI) AFTER BARIATRIC SURGERY IN<br />
OBESE PATIENTS - J. Benigni<br />
DIA3 HUNGARIAN NAMES IN THE PHLEBO-LYMPHATIC CLINICAL RESEARCH - I. Bihari<br />
DIA4 LESS RECURRENT VARICOSIS OF THE SAPHENOFEMORAL JUNCTION BY PERFORMING MODIFIED CONTINUOUS SUTURE OF THE<br />
FEMORAL VEIN? - M. Broermann<br />
DIA5 LASER VEIN THERAPY ASSOCIATED TO SCLEROTHERAPY OF ISOLATED TELANGIECTASIAS. PERSONAL PROSPECTIVE EVALUATION<br />
C. Burtica<br />
DIA6 FREQUENCY OF INTIMA-MEDIA THICKNESS INCREASE AND OF ATHEROSCLEROTIC PLAQUES IN ASYMPTOMATIC PATIENTS<br />
M. Cazaubon<br />
DIA7 ENDOVENOUS LASER TREATMENT (EVLA) OF GASTROCNEMIUS VEIN REFLUX WITH 1320NM - 2 CASE REPORTS - P. Chapman-Smith<br />
DIA8 CONTEMPORARY METHODS OF SURGICAL TREATMENT OF VARICOSE DISEASE IN LOWER LIMBS VEINS - A.I. Chernookov<br />
DIA9 STEP BY STEP OF ENDOVASCULAR LASER PROCEDURE FOR TREATING VARICOSE VEINS: OUR EXPERIENCE - L. Narvaes<br />
DIA10 LAPAROSCOPIC VARICOCELECTOMY - A. Cotirlet<br />
DIA11 PYODERMA GANGRENOSUM-RARE COMPLICATION OF SCLEROTHERAPY - E. De Felice<br />
DIA12 THE “PUSH-UP”: AN ORIGINAL TECHNIQUE FOR THE SURGICAL CORRECTION OF RECTO-HAEMORRHOIDAL PROLAPSE. PERSONAL<br />
EXPERIENCE - F. Di Benedetto<br />
DIA13 LEG ULCERS IN THE PATIENT WITH KLIPPEL-TRENAUNAY SYNDROME - A CASE REPORT - K. Djukic<br />
DIA14 AMBULATORY TREATMENT OF VARICOUS VEINS – POSSIBILITIES AND LIMITS - C. Duta<br />
DIA15 LATE COMPLICATIONS THE SEQUEL OF DEEP VENOUS THROMBOSES GROZDINSKI L., M. STANKEV, A. DRAMOV NATIONAL HOSPITAL<br />
OF CARDIOLOGY, DEPARTMENT OF VASCULAR SURGERY AND ANGIOLOGY, SOFIA, BULGARIA - L. Grozdinski<br />
DIA16 THE TRUE CAUSE OF VARICOSE VEINS IS CHAIR-SITTING - M. Oswald<br />
Posters presented on Tuesday, September 1 st from 14.00 to 15.00 (Diaghilev area)<br />
DIA17 THE A OF CEAP: IMAGING OF VEIN WALLS - T. Alekperova<br />
DIA18 EVALUATION OF A NOVEL TWO LAYER COMPRESSION STOCKING SYSTEM IN THE TREATMENT OF VENOUS LEG ULCERS<br />
J. Benigni<br />
DIA19 RECURRENCES OF THE SAPHENOFEMORAL JUNCTION DUE TO AN INCOMPENTENT PERSISTING SUPERFICIAL EPIGASTRIC VEIN<br />
M. Broermann<br />
DIA20 TWO CASES OF THE VENOUS ANEURYSMAL DISEASE, TRUE AND PSEUDOANEURYSM OF EXTREMITY SUPERFICIAL VEINS<br />
I. Jung<br />
DIA21 ENDOVENOUS 980-NM LASER TREATMENT OF SMALL SAPHENOUS VEINS: HOW MUCH ENERGY DO WE NEED?<br />
SH. Kang<br />
DIA22 HISTOMORFOLOGY OF CALF MUSCLES AT PATIENTS WITH PRIMARY CHRONIC VENOUS INSUFICIENCY BEFORE AND AFTER<br />
SURGERY<br />
A. Kasparov<br />
DIA23 RELATIONSHIP BETWEEN THERMAL EFFECT AND CARBON CAP FORMED AT THE END OF LASER FIBER FOR 810NM EVLT<br />
PROCEDURE<br />
M. Kawada<br />
DIA24 MASSIVV - MEN WITH ABUNDANCE SEXUAL STEROID HORMONES IN VARICOSE VEINS.<br />
M. Kendler<br />
DIA25 EXTERNAL BANDING VALVULOPLASTY FOR INCOMPETENCE OF THE GREAT SAPHENOUS VEIN: A 10-YEAR RESULTS<br />
D. Kim<br />
DIA26 ENDOVENOUS LASER TREATMENT (EVLT) OF VARICOSE VEINS - S. Kirgizbayev<br />
DIA27 PREOPERATIVE COLOR DUPLEX ULTRASOUND IN VARICOSE VEIN SURGERY - I. Kostov<br />
DIA28 ENDOVENOUS LASER ABLATION FOR COSMETIC TREATMENT OF SUPERFICIAL VEINS OF THE FACE - L. Narvaes<br />
DIA29 ENDOVENOUS LASER TREATMENT FOR RECURRENT VARICOSE VEINS AFTER SAPHENO-FEMORAL JUNCTION LIGATION<br />
N. Kurihara<br />
DIA30 VNUS SURGERY. FIRST EXPIRIENCE OF 30 PROCEDURS - O. Loginov<br />
DIA31 MINIINVASIONAL TREATMENT OF CHRONIC VENOUS INSUFFICIENCY - N. Salimzhanov<br />
Posters presented on Wednesday, September 2 nd from 14.00 to 15.00 (Diaghilev area)<br />
DIA32 SMALL SAPHENOUS VEIN TREATED BY ULTRASOUND GUIDED FOAM SCLEROTHERAPY - S. Kang<br />
DIA33 CHRONIC VENOUS DISEASE: PHARMACOTHERAPY WITH RED VINE LEAF EXTRACT - T. Alekperova<br />
DIA34 PODOCONIOSIS: A SPECIAL FORM OF LYMPHOEDEMA - M. Mooijj<br />
DIA35 NARROWING OF SUPERFICIAL AND DEEP VEINS BY A READY-TO-WEAR COMPRESSION DEVICE DEMONSTRATED BY MAGNETIC<br />
RESONANCE IMAGING - G. Mosti<br />
DIA36 ELASTIC COMPRESSION STOCKING AFTER ENDOVENOUS LASER ABLATION OF THE GREAT SAPHENOUS VEIN - L. Narvaes<br />
DIA37 NERVOUS RELATIONSHIPS OF THE SHORT SAPHENOUS VEIN - J. Uhl<br />
DIA38 ASSOCIATION OF CROSECTOMY AND FOAM SCLEROTHERAPY IN THE TREATMENT OF VENOUS ULCERATIONS AT ELDERLY<br />
PATIENTS<br />
M. Kowalski
DIA39 TREATMENT OF VENOUS ULCERS WITH CRONOCOL IMPLANTS – ANALYSIS OF 10 CASES - C. Costa Almeida<br />
DIA40 UNDERSTANDING OF DVT IS SUPERIOR TO KNOWLEDGE ABOUT IT - M. Oswald<br />
DIA41 MANAGEMENT OF ISOLATED CALF DEEP VEIN THROMBOSIS - S. Ota<br />
DIA42 BIOMEDICAL ENGINEER AND PHLEBOLOGIST: A MIDSHIP FRAME - P. Van Dale<br />
DIA43 SUGAR AND HONEY: CHEAP MEDICATIONS FOR THE VENOUS ULCER - F. Passariello<br />
DIA44 THE INCIDENCE OF MALIGNANT DISEASES AMONG PATIENTS WITH DEEP VEIN THROMBOSIS OF LOWER EXTREMITY - D. Milic<br />
DIA45 SEVERE DRUG-INDUCED SKIN REACTION AFTER SCLEROTHERAPY - A. Reichelt<br />
DIA46 LASER THERAPY IN TREATMENT OF ANGIOPATHY OF LOW EXTREMITIES OF CHRONIC VENOUS INSUFFICIENCY - N. Salimzhanov<br />
Posters presented on Thursday, September 3 rd from 14.00 to 15.00 (Diaghilev area)<br />
DIA47 PHLEBOSCLEROSING TREATMENT OF VARICOSE DISEASE USING THE «FOAM-FORM» TECHNIQUE - N. Salimzhanov<br />
DIA48 THE GRAPH CLASSIFICATION FOR THE VENOUS SYSTEM OF THE LOWER LIMBS - F. Passariello<br />
DIA50 SURGICAL INTERVENTIONS OF RECURRENCES OF THE SAPHENOFEMORAL JUNCTION IN TUMESCENT LOCAL ANAESTHESIA<br />
S. Schattenkirchner<br />
DIA51 BILATERAL ILIOFEMORAL THROMBOSIS IN 19-YEAR-OLD FEMALE WITH ABSENCE OF SUPRARENAL SEGMENT OF INFERIOR VENA<br />
CAVA AND HEREDITARY THROMBOPHILIA - CASE REPORT - M. Sebo<br />
DIA52 HYPOTHETICAL CELLULAR AND MOLECULAR MECHANISMS OF THE DEVELOPMENT OF A VENOUS LEG ULCER - M. Simka<br />
DIA53 ASSESSMENT OF THE QUALITY OF LIFE IN WOMEN WITH VENOUS DISEASE - C. Taïeb<br />
DIA54 NOBLE METHOD FOR GREAT SAPHENOUS VEIN TRUNK SCLEROTHERAPY UNDER BALLOON OCCLUSION AT SAPHENO - FEMORAL<br />
JUNCTION - ITS SAFETY AND EARLY RESULTS - H. Tashiro<br />
DIA55 SARCOIDOSIS MIMIKING THE LEG ULCERS IN THE PATIENT WITH CHRONIC VENOUS INSUFFICIENCY - A CASE REPORT<br />
O. Tomanovic Andonovic<br />
DIA56 EARLY RESULT OF RHEOLYTIC THROMBECTOMY IN PATIENTS WITH PROXIMAL - A. Tsuji<br />
DIA57 ENDOVENOUS ABLATION OF THE GREAT SAPHENOUS VEIN WITH LASER 980NM AND 1470NM COMPARING WITH CONVENCIONAL<br />
SURGERY IN PATIENTS WITH VARICOSE VEINS: SHORT TERM RESULTS - L. Narvaes 1<br />
DIA58 THE FOOT VENOUS PUMP : ANATOMY AND PHYSIOLOGY - J. Uhl<br />
DIA59 ADVANCE PHLEBOLOGY TREATMENT - 5 YEARS OWN EXPERIENCE - K. Wasilewski<br />
DIA60 COST-EFFECTIVE-TRAINING DEVICE FOR MICRO FOAM ULTRASOUND-GUIDED SCLEROTHERAPY [UGS] FOR VARICOSE VEIN<br />
TREATMENT<br />
J. Wulf<br />
DIA61 AMBULATORY PHLEBECTOMY IN THE TREATMENT OF VARICOSE VEINS - S. Zivic<br />
LIST OF ACCEPTED VIDEOS<br />
which are running continously every day from 9.00 to 18.00<br />
in Diaghilev Exhibition area<br />
VIDEO 1 CORRELATIONS BETWEEN INTERFACE PRESSURE MEASUREMENTS AND A CT SCAN WITH 3D RECONSTRUCTION UNDER SPECIFIC<br />
ECCENTRIC COMPRESSION AT THE THIGH LEVEL<br />
J. Benigni<br />
VIDEO 2 SEPS - THE WAY WE TREAT INCOMPETENT PERFORATORS<br />
C. Costa Almeida<br />
VIDEO 3 RETICULAR VEINS ON THE FACE: EXPERIENCE OF SEVEN YEARS ON LASER TREATMENT<br />
F.H. Duarte<br />
VIDEO 4 3D VIRTUAL TRIP IN THE VENOUS SYSTEM<br />
J. Uhl<br />
VIDEO 5 VIDEO COMPARISON OF IN VIVO AND IN VITRO PATTERNS OF FOAM SCLEROSANT DISTRIBUTION<br />
J. Ragg<br />
VIDEO 6 IMPROVING VARICOSE VEIN SURGERY WITH TRANSILLUMINATION<br />
A. Reichelt<br />
VIDEO 7 GREAT SAFENOUS VEIN ABLATION WITH LASER 1470 USING RADIAL EMISSION OPTICAL FIBER<br />
A. Reichelt<br />
VIDEO 8 ENDOVENOUSLASER:9 YEARS EXPERIENCE- LESSONS LEARNED<br />
A. Reichelt<br />
VIDEO 9 ENDOSCOPIC ASPECT OF ULTRASONIC GUIDANCE SCLEROTHERAPY WITH FOAM<br />
F. Vin<br />
VIDEO 10 ENDOVENOUS LASER ABLATION. DOES VEIN SIZE COMPROMISE SUCCESS?<br />
H. J. Poczwa<br />
41
42<br />
S C I E N T I F I C I N F O R M A T I O N<br />
AUDIO-VISUAL FACILITIES<br />
Speakers must go to the preview room VAN DONGEN, located on level - 2 of the Grimaldi<br />
Forum, in order to validate and download their presentation files according to the following<br />
schedule:<br />
• Morning Sessions: no later than the afternoon of the day before their communication.<br />
• Afternoon Sessions: no later than noon of the day of their communication.<br />
Please respect this schedule, otherwise, the performance of the received presentations is not<br />
guaranteed.<br />
We cannot accept presentations delivered in room directly (without previewing).<br />
Coffee breaks and midday are the busiest time in the preview room. So we recommend you to<br />
come to the preview early in the morning or during other presentations.<br />
Preview technical staff will guide and assist the speakers for checking and downloading their<br />
presentation files.<br />
A training computer will be available in order to help the speaker to use and be comfortable<br />
with the preview software and equipment in the conference room.<br />
The preview room will be open:<br />
• Sunday, August 30 th : from 15.00 to 19.30<br />
• From Monday, August 31 st to Thursday, September 3 rd : from 07.30 to 19.30<br />
both days included<br />
• On Friday, September 4 th : from 07.30 to 14.00<br />
ACCREDITATION<br />
The congress has been designated for 30 European CME credits (UEMS). Please come to the<br />
Registration desk for further information<br />
CERTIFICATE OF ATTENDANCE<br />
A Certificate of attendance is provided on request at the Registration desk.<br />
POSTERS EXHIBITION (Diaghilev area - Level -1)<br />
An area has been prepared for poster exhibition for viewing and discussing with the authors<br />
from 14.00 to 15.00, according the following schedule:<br />
• Monday, August 31st : posters DIA 1 to 16<br />
• Tuesday, September 1st : posters DIA 17 to 31<br />
• Wednesday, September 2nd : posters DIA 32 to 46<br />
• Thursday, September 3rd : posters DIA 47 to 61<br />
Authors must attend their poster display during the assigned sessions.<br />
Each poster session will be chaired by the poster General Chairmen and moderated by two<br />
Poster Discussants named by the congress’ Committee every day.<br />
A winner for the best poster will be elected on each session.<br />
Posters should be set up as soon as possible from Monday, August 31st on the board number<br />
assigned to your poster(s) and must remain displayed as long as possible.<br />
Posters should be removed on Friday afternoon from 17.00. All posters not removed will be<br />
destroyed.<br />
VIDEO THEATRE<br />
Accepted videos are running continously every day from 09.00 to 18.00 in Diaghilev Exhibition area.
VENOSAN ® is a registered trademark of SALZMANN AG, St.Gallen, Switzerland.<br />
Goodbye Tired Legs!<br />
Platinum Sponsor of the<br />
www.venosan.com
44<br />
E X H I B I T I O N P L A N
L I S T O F E X H I B I T O R S<br />
Companies Stands<br />
AD REM TECHNOLOGY 23<br />
<strong>AIM</strong> GROUP / DTC S3<br />
ANGIODYNAMICS UK LTD 14<br />
BAUERFEIND AG 27 + 18<br />
BIOLITEC AG 22<br />
CELON AG MEDICAL INSTRUMENTS 21<br />
CIZETA MEDICAL SPA 20<br />
COVIDIEN 9<br />
ESAOTE FRANCE 13<br />
ETS THUASNE 11<br />
EUFOTON SRL 16<br />
FILMAR SRL 24<br />
GEBRUEDER MARTIN GMBH & CO. KG 19<br />
GIBAUD 12<br />
GLORIAMED SRL 6<br />
GUTMANN MD GMBH S2<br />
HK SURGICAL INC. S1<br />
INNOTHERA 10<br />
KREUSSLER PHARMA 8 + 8BIS<br />
MEDI GMBH & CO. KG 26<br />
MINERVA MEDICA 17<br />
PIERRE FABRE 4<br />
RADIANTE - JOBST 3<br />
SERVIER INTERNATIONAL 5<br />
SIGVARIS 7<br />
STD PHARMACEUTICALS PRODUCTS LTD 26<br />
VENOSAN - SALZMANN GROUP 1 + 2<br />
VENOUS TIMES TABLE TOP<br />
VNUS MEDICAL TECHNOLOGIES GMBH 25<br />
WAGNER MEDICAL 15<br />
Village of Societies Stands<br />
<strong>UIP</strong> (Union Internationale de Phlébologie) 30<br />
ACP (American College of Phlebology) 31<br />
DGP (German Society of Phlebology) 32<br />
SFP (Société Française de Phlébologie) 33<br />
VASCULAR NEWS 34<br />
ROYAL SOCIETY OF MEDECINE PRESS 35<br />
Internet Point Stands<br />
VENOSAN - SALZMANN GROUP I1<br />
RADIANTE - JOBST I2<br />
MEDI GMBH & CO. KG I3<br />
BAUERFEIND AG I4<br />
SIGVARIS I5<br />
45
46<br />
ADMISSION<br />
G E N E R A L I N F O R M A T I O N<br />
The participant’s name badge is provided at the registration desk. All participants are requested<br />
to wear the badge throughout the Congress, including the Opening Ceremony and Welcome<br />
reception.<br />
CASH DISPENSER<br />
A cash machine is located on the entrance level next to the information desk of the Grimaldi<br />
Forum.<br />
COFFEE BREAKS<br />
During the Congress breaks, coffee, tea and refreshments are served free of charge to all<br />
registered participants wearing Congress badges.<br />
CONGRESS VENUE<br />
GRIMALDI FORUM: 10, Avenue Princesse Grace - Ph +377 99992000<br />
The Forum Grimaldi is the Convention Centre for the third millennium.<br />
Daringly built out over the sea, it is an architectural challenge consisting of a total area of over<br />
35.000 mq, split on various levels in order to enable different events to be held simultaneously<br />
and yet independently.<br />
During the congress you can discover the Grimaldi’s summer exhibition: "Moscou: Splendeurs<br />
des Romanov" situated on the 1st floor (Ravel space). As participant of the congress you will<br />
benefit from 25% reduction on the official price. Reduced price is € 7.50 instead of € 10.00.<br />
CURRENCY<br />
The currency in Monaco is the Euro. There are a number of currency exchanges which are<br />
open all day, including Sunday and bank holidays.<br />
Your hotel will provide you with details of your nearest currency exchange.<br />
ELECTRICITY<br />
The standard voltage in the Principality of Monaco is 220 V. Plugs are a two-pin style, continental.<br />
EXHIBITION (Located in Diaghilev floor, level -1) - (see plan page 44)<br />
In this industrial exhibition, diagnostic, pharmaceutical and other companies of related matters<br />
from all over the world, will be given the opportunity to put on display their products, services<br />
and new technical solutions. It provides a valuable forum to share pratical ideas and to discuss<br />
recent advances and future trends.<br />
The technical infrastructure of the Grimaldi Forum is of highest standard; its versatile infrastructure<br />
offers ample possibilities to build attractive stand constructions.<br />
VILLAGE OF SOCIETIES-INTERNET POINT - (see plan page 44)<br />
As part of the XVI World Meeting of the <strong>UIP</strong>, a Village of Societies and an Internet Point are<br />
located in the exhibition hall Diaghilev of the Grimaldi Forum, close to all other Congress<br />
activities such as scientific sessions, poster exhibition, registration and recreation areas etc.
LANGUAGE<br />
G E N E R A L I N F O R M A T I O N<br />
The official language of the Congress is English.<br />
Simultaneous translation is not provided for this congress.<br />
LIABILITY<br />
The Congress organizers shall only be liable for the delegates and their accompanying persons<br />
in case of gross negligence or willful misconduct in the deliverance of their obligations under<br />
the event agreement. The Congress organizers shall accept no responsibility or liability for<br />
events such as accidents, thefts or losses of property etc, as the delegates and accompanying<br />
persons are responsible for their own insurance.<br />
Registration does not include insurance.<br />
OPENING CEREMONY RECEPTION<br />
The Opening Ceremony will be held on Sunday, August 30th in room Prince Pierre followed<br />
by a cocktail in the Exhibition hall Diaghilev.<br />
TRANSFERS FROM NICE AIRPORT TO MONACO AND RETURN<br />
• By taxi: Prices for taxi transfers from Nice Airport to Monaco and return are approximately<br />
€ 80 (one-way day fare) or € 100 (one-way night fare). Taxis are available outside the Airport<br />
or can be ordered 24 hours a day by calling the following numbers:<br />
from Monaco: +377 93 15 01 01<br />
from Nice: +33 4 93 13 78 78<br />
• By public bus: Regular daily connections (Nice Airport - Monaco and/or return). Departures<br />
from Terminal 1 and 2 every hour, from 09.00 to 21.00. Duration 45 minutes - Price per way<br />
and per person: € 18<br />
• By helicopter: The Monaco Heliport, located right by the sea, offers numerous daily connections<br />
from Nice Airport - to Monaco and / or return with a duration of only 6 minutes flying.<br />
Upon arrival in Monaco, a shuttle will take you to your requested destination in the Principality<br />
of Monaco.<br />
- Contact details for Heli Air Monaco:<br />
e-mail: fabien@heliairmonaco.com - phone: +377 92 050 050 - fax: +377 92 050 036 -<br />
website: www.heliairmonaco.com. You may benefit from the following special Congress'<br />
rates if you indicate that you are attending the "XVI World Meeting of <strong>UIP</strong>".<br />
Nice - Monaco: € 100 per person (normal price € 120)<br />
Monaco - Nice: € 85 per person (normal price € 105)<br />
Return fare: € 175 per person (normal price € 210)<br />
HOW TO CIRCULATE IN MONTE CARLO<br />
(bus plan available in the Congress bag)<br />
Public bus transportation in Monaco is free for participants showing the Congress badge, from<br />
Saturday 29 th August to Saturday 5 th September (both days included).<br />
47
48<br />
G E N E R A L I N F O R M A T I O N<br />
TRAVELLING BY CAR<br />
Eastbound on A8 highway, please take the exit "Monaco/Cap d'Ail". Westbound, please take<br />
the exit "Roquebrune Cap Martin".<br />
Kindly note that 33 public car parks are available in the Principality of Monaco. If you park your<br />
car in the Grimaldi Forum car park, you may benefit from a special Congress' fare, provided that<br />
you get a special form from the Congress' Secretariat desk located in the main hall.<br />
TRAVELLING BY TRAIN<br />
The Grimaldi Forum is 15 minutes walking distance from the railway station and 5 minutes<br />
by public bus (line n° 4 - direction Larvotto). Use of Monaco Buses is free for delegates upon<br />
presentation of their official congress name tag.<br />
REGISTRATION FEES<br />
On-site registration (VAT 19,6% to be added):<br />
Physicians € 850<br />
Members of the DGP or of the SFP € 400<br />
Live-in nurses vascular technologists € 500<br />
Accompanying persons € 60<br />
Congress Gala dinner (1 st September) € 100<br />
SECRETARIAT DESK<br />
The Secretariat desk will be open during the following hours:<br />
Sunday, 30 th August <strong>2009</strong>: 09.30 - 20.30<br />
Monday, 31 st August <strong>2009</strong>: 07.30 - 18.30<br />
Tuesday, 1 st September <strong>2009</strong>: 07.30 - 18.30<br />
Wednesday, 2 nd September <strong>2009</strong>: 07.30 - 18.30<br />
Thursday, 3 rd September <strong>2009</strong>: 07.30 - 18.30<br />
Friday, 4 th September <strong>2009</strong>: 07.30 - 18.30
Monaco City Map<br />
50
Monaco<br />
de<br />
Publi Créations - Partner of <strong>AIM</strong><br />
Presse de<br />
74, Bd d’Italie - 98000 Monte-Carlo - Monaco<br />
Centre<br />
Ph.: +377 97 97 3555 - Fax: +377 97 97 3550<br />
©Photos -<br />
E-mail: info@publicreations.com<br />
Website: www.publicreations.com <strong>p08126</strong>